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CHAPTER I 
 
INTRODUCTION 
 
 Telomeres are the protein-DNA complexes found at the termini of linear 
chromosomes in eukaryotic organisms.  These regions maintain chromosome integrity by 
distinguishing normal chromosome ends from double-strand breaks and preventing end-
to-end fusions.  Without a means to combat the progressive shortening of telomeres 
following each replication cycle, cells undergo senescence and cease to divide.  While 
telomere shortening serves to limit cell proliferation and acts as a tumor-suppressor in 
somatic cells, germ-line and stem cell populations require continuous renewal.  
Therefore, a mechanism is required to maintain telomere lengths.  In eukaryotes, except 
Dipterans, this task is accomplished by the enzyme telomerase.  Telomerase is a multi-
subunit ribonucleoprotein and adds TG-rich telomere repeats by reverse transcribing a 
short template region contained in its intrinsic RNA component.  Telomerase activity is 
highly regulated, being controlled temporally, post-translationally, and physically.  
Because telomere structure is evolutionarily conserved, general insight into telomere 
maintenance can be gleaned from organisms that are genetically malleable, such as the 
yeast S. cerevisiae used in this study.   
 For this dissertation, I focus on the temporal regulation of telomerase assembly by 
protein degradation of a core subunit during G1 phase of the cell cycle (Chapters II and 
III).  In Chapter V, I discuss the conclusions and future directions of this project and offer 
a critique of the standard assays used for addressing fundamental questions about cell 
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cycle-regulated protein degradation.  In this section (Chapter I), I detail the history of 
telomere biology and our current understanding of telomerase regulation in yeast.  I then 
present an introduction of protein degradation, and specifically, the Anaphase Promoting 
Complex (APC).   
 
A History of Telomeres and Telomerase 
 
Discovery of telomeres 
 During the 1920’s and 30’s, Hermann Müller irradiated fruit flies to generate 
mutants with chromosome abnormalities such as translocations, inversions, and deletions.  
Interestingly, he was unable to identify any mutants in which the natural end of a 
chromosome was involved in such an event.  He concluded that the end of the 
chromosome must serve a special function critical for organismal survival and coined the 
term “telomere” for this region, derived from the Greek word “telos” meaning end and 
“meros” meaning part [1].  During this same time, Barbara McClintock was also studying 
the chromosome in a different system, maize.  Like Hermann Müller, she used irradiation 
as a means to introduce chromosome abnormalities and found that while broken 
chromosomes fused to each other, the natural chromosome termini were never involved 
in these fusion events [2].  Therefore, these two pioneers independently postulated that 
the natural end of a chromosome exhibits special qualities important for chromosome 
stability and organism survival, namely that of preventing chromosome fusions. 
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The end-replication problem 
 The next 30 years after the initial observations by Drs. Müller and McClintock 
saw little telomere research progression.  However, the discovery of the chemical 
composition and structure of DNA by Drs. James Dr. and Francis Crick in 1953 [3], the 
identification of DNA polymerase I by Dr. Arthur Kornberg in 1956 [4-6], and the 
understanding of lagging strand replication by Reiji Okazaki in 1967 [7] pushed research 
forward toward investigating the molecular mechanisms of DNA replication.  In the early 
1970’s, two independent researchers, Drs. James Watson and Alexey Olovnikov each 
proposed that the chromosome termini would pose a particular problem during 
replication.  During DNA replication, the two parental strands separate and are used as a 
template for the production of two complete DNA molecules.  DNA polymerases 
synthesize in a 5’– to – 3’ direction, requiring a free 3’-hydroxyl (3’-OH) for successive 
base incorporation.  Therefore, while leading strand synthesis proceeds continuously, 
lagging strand replication occurs in sections, called Okazaki fragments, which are 
initiated by the synthesis of an RNA primer.   In his 1971 paper, Dr. Olovnikov suggested 
that the end of the chromosome cannot be completely replicated because the DNA 
polymerase is unable to fill in the 5’-gap or 3’-overhang that remains following the 
removal of the RNA primer from the terminus of the lagging strand.  He concluded that 
this incremental loss of sequence from the end of chromosomes could result in loss of 
critical genomic information [8].  Dr. Watson developed a very similar model and 
published his conclusions in 1972.  Here he termed this phenomenon of incomplete 
copying of the DNA template “the end-replication problem” [9].  However, Dr. 
Olovnikov took his model one step further; he proposed that the incremental shortening 
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of the chromosome termini each replication cycle acts as a counting mechanism for 
cellular aging and explains the limited potential for divisions (senescence) that Dr. 
Leonard Hayflick and others described in the 1960’s [10-12].   
Dr. Olovnikov’s work went largely unrecognized because his manuscript was 
originally published in a Russian journal with few US readers.  Furthermore, when finally 
able to present his work at an international meeting held in Kiev, Ukraine, the sudden 
disappearance and suspected kidnapping of Dr. Zhores Medvedev, a friend of Dr. 
Hayflick and prominent biochemist, distracted the audience and his presentation was 
largely ignored.  It turned out that Dr. Medvedev was followed to the conference, forcibly 
detained, and escorted back to Moscow by the Soviets.  In 1973, Dr. Olovnikov was 
allowed to re-publish his 1971 manuscript in English in the Journal of Theoretical 
Biology.   However, Dr. Watson, a more prominent figure in the field, was still viewed as 
publishing first (1972) and therefore continued getting full credit for realizing and 
modeling the end-replication problem.  Between 1972 and 1990, Dr. Watson’s paper was 
cited 225 times, while Dr. Olovnikov’s received only four citations.  Dr. Olovnikov was 
later quoted, “I was glad that I, a young researcher, was ahead of the Nobel Laureate in 
several central positions” [13].  Drs. Calvin Harley, Bruce Futcher, and Carol Greider 
thrust Dr. Olovnikov’s work into the spotlight with the number one reference in their 
groundbreaking 1990 Nature article documenting that, as predicted, telomeres shorten as 
human fibroblasts age [14]. 
The model proposed by Drs. Olovnikov and Watson for the end-replication 
problem was revised following the discovery that the telomere constitutively exists with a 
3’-overhang [15-17].  Therefore, telomere attrition is a consequence of leading-strand   
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Figure 1.  Model of the end-replication problem. 
(1) During replication, each strand acts as a template for the synthesis of a 
complementary strand.  (2) Lagging strand replication (pink) recreates a 3’ overhang 
following removal of the terminal RNA primer (lime).  Leading strand replication (light 
blue) results in a blunt-ended molecule that undergoes exonucleolytic resection (orange 
“pac-man”) of the 5’ end to re-establish the normal 3’ overhang.  (3) The end product has 
a 3’ overhang on each new dsDNA molecule.  Additionally, there is shortening of the 
parental strand involved in leading strand replication, as compared to the starting length 
(dashed vertical line).  Additional rounds of replication further shorten the leading 
parental strand length (gray box).  Black circles represent centromeres.  
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replication that results in a blunt-ended molecule, and the 5’-strand resection that occurs 
to recreate the 3’-overhang (Figure 1; also see section “Telomere Structure”). 
 
Sequencing the telomere 
 Following the theoretical modeling of the end-replication problem, research 
interest in telomere biology was reignited and turned toward determining the sequence of 
telomeres.  Dr. Elizabeth Blackburn, working with the ciliate Tetrahymena thermophila 
in the lab of Dr. Joseph Gall, realized that this organism would be ideal for these types of 
experiments.  Tetrahymena is a pond-dwelling, unicellular organism with two 
functionally distinct nuclei: a germ-line micronucleus that is transcriptionally silent, and a 
somatic macronucleus that is transcriptionally active.  The micronucleus is diploid and 
contains 5 chromosomes; the macronucleus is highly polyploid resulting from the 
breakup of the five chromosomes into mini-chromosomes. Since these mini-
chromosomes are then amplified multiple times and a telomere is added to each end, the 
maturation of the macronucleus results in ~40,000 telomeres in a single Tetrahymena cell 
[18], a great enrichment over other species such as diploid S. cerevisiae (64 telomeres) or 
H. sapiens (92 telomeres). 
 In 1978, Dr. Blackburn purified and sequenced telomeres from the macronucleus 
in Tetrahymena and discovered that they consist of tandem repeats of a hexanucleotide 
unit TTGGGG/CCCCAA, with the G-rich strand present at the 3’ terminus.  These 
telomeres were also found to be heterogeneous in the number of repeats they contained, 
varying from 20 to 70, and averaging 300 base pairs (bp) in length [19].  In 1995, Drs. 
Karen Kirk and Elizabeth Blackburn reported that the micronucleus consists of telomeres 
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containing the same terminal tandem repeats, but these telomeres are seven times longer 
(2-3.4 kilo-base pairs (kbp)) than those found in the macronucleus [20].  Over the next 
few years, the telomeres from other ciliates were sequenced and found to be comprised of 
similar tandem repeats [18].  
 Since the telomeres of ciliates were found to contain very similar tandem repeats 
despite being distantly related, researchers started examining the conservation of this 
aspect of telomere biology.  In 1982, Drs. Elizabeth Blackburn and Jack Szostak found 
that telomeres of one species could be recognized by a different species.  In this work, a 
plasmid was linearized to expose Tetrahymena telomeres on each end and introduced into 
S. cerevisiae.  Surprisingly, this linear piece of DNA was maintained through multiple 
generations.  In each case, the telomeres were elongated by the addition of yeast-specific 
repeats 100-300 bp in length, suggesting the yeast telomere maintenance mechanism was 
able to recognize and act upon the foreign Tetrahymena sequence.  This plasmid was then 
used as a tool to clone yeast telomeres.  One Tetrahymena telomere was removed and 
replaced with a library of yeast chromosomal restriction fragments; those that resulted in 
retention of the linearized plasmid mapped to the yeast telomere [21].  In 1984, S. 
cerevisiae telomeres were cloned and found to be ~300 bp in length and composed of 
tandem repeats with an irregular pattern, denoted T(1-3)G [22].  The finding that telomeres 
could be recognized and elongated by other species suggested that a recombination or 
fold-back method of replication was improbable and rather that telomere replication was 
likely to be mediated through some type of enzymatic activity.   
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Discovery of telomerase 
 After sequencing telomeres from multiple organisms and demonstrating that their 
maintenance is evolutionarily conserved, research interest shifted toward identifying the 
molecular players and mechanism of telomere replication.  As described above, since 
telomeres in the macronucleus of Tetrahymena are heterogeneous in length [19], and S. 
cerevisiae telomere sequences can be added to Tetrahymena telomeres being maintained 
in yeast [21], Dr. Blackburn hypothesized that telomeres are maintained by a terminal 
transferase.  In 1985, Drs. Carol Greider and Elizabeth Blackburn found that a single 
stranded (ss) primer containing Tetrahymena or S. cerevisiae telomeric DNA could be 
extended in a 6-base repetitive pattern in the presence of Tetrahymena protein extract, 
dGTP, and dTTP, consistent with the known telomere sequence (TTGGGG).  They were 
unable to detect this activity using a non-telomeric primer.  Furthermore, the reaction was 
unaffected by pre-treatment with micrococcal nuclease to remove the endogenous 
Tetrahymena double stranded (ds) DNA but was inhibited by proteinase K treatment and 
heat denaturation [23].  Drs. Greider and Blackburn also reported that telomere addition 
is inhibited in the presence of RNase [24].  Collectively, this work demonstrated that 
enzymatic activity from a ribonucleoprotein (RNP), which they named telomere terminal 
transferase (telomerase), was responsible for telomere additions. 
 Armed with the knowledge that telomerase was an RNP, Drs. Greider and 
Blackburn hypothesized that the telomere repeat sequence may be specified in the RNA 
component.  Following a multi-step purification process of Tetrahymena telomerase, a 
159 base RNA repeatedly co-purified with telomerase activity.  This RNA was then 
sequenced and found to contain a region (5’-CAACCCCAA-3’) that was complementary 
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to the Tetrahymena telomere repeat (5’-TTGGGG-3’).  The authors hypothesized that 
this region acted as the template for DNA synthesis by the telomerase enzyme.  In 
support of this idea, in vitro telomerase activity was inhibited by an anti-sense 
oligonucleotide that hybridized across this region.  Likewise, a G-rich oligonucleotide, 
whose 3’ end was complementary to the region immediately adjacent to the template, was 
elongated by telomerase.  From this work, a mechanism of telomerase action (Figure 2) 
was proposed: 1) the 3’ end of the telomere hybridizes to the RNA template region, 2) 
telomerase adds sequence one nucleotide at a time by reverse transcription, 3) the enzyme 
translocates and the new 3’ end hybridizes to the RNA template, and 4) elongation of the 
sequence occurs again [25].  Remarkably, this model is still essentially correct today.  
 In 1990, the proposed template portion of the Tetrahymena RNA (5’-
CAACCCCAA-3’) was mutated.  These mutations were incorporated into newly 
synthesized native telomeres in vivo, demonstrating that telomerase is a reverse 
transcriptase that uses the template region provided by its own internal RNA component.  
Importantly, one template mutant failed to incorporate any of the sequence onto telomere 
ends.  This mutant instead underwent progressive telomere shortening and eventual 
senescence, suggesting that telomerase activity is necessary for cellular lifespan [26], as 
predicted by Dr. Olovnikov nearly 20 years earlier [10].   Telomerase activities were 
found in other ciliates (Oxytricha and Euplotes) [27,28] and in humans in the late 1980’s 
[29].  Each telomerase synthesized its own species-specific G-rich telomere repeat using 
a template provided from an RNA molecule essential to telomerase activity [30,31]. 
In 1997, the catalytic subunit of telomerase from the ciliate Euplotes was purified 
and the gene encoding this protein was cloned [32].  After a BLAST search of protein   
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Figure 2.  S. cerevisiae telomere elongation. 
The telomeric 3’ overhang is complementary to the template region of the TLC1 RNA 
molecule, but can base-pair in a variety of alignment orientations (blue gradient).  Upon 
alignment, telomerase reverse-transcribes the template region one base at a time, called 
nucleotide addition processivity (various colors).  The enzyme then translocates and 
synthesizes an additional telomere repeat, called repeat addition processivity (red).  The 
multiple template alignment registers and incomplete copying (abortive synthesis) of the 
template contributes to the degenerate sequence of yeast telomeres. 
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databases, this protein (p123) was found to be similar to the recently identified S. 
cerevisiae telomerase component, Est2p [33].  A detailed discussion of the screen that 
identified Est2p is below.  The sequence identity between Est2p and p123 was only 20%, 
but similarity could be identified across the length.  Closer inspection of this sequence 
revealed reverse-transcriptase motifs within both p123 and Est2p.  Mutation of these 
conserved motifs in Est2p caused short telomeres and eventual senescence, indicating 
importance of these regions to telomere maintenance in vivo.  Likewise, in vitro activity 
depended upon the expression of EST2 and the RNA component, TLC1 [32].  Soon after, 
catalytic subunits from other organisms were identified, including mouse [34], S. pombe 
[35], and humans [35,36], demonstrating the conservation of the telomerase enzymatic 
core across taxa.  In 1998, the catalytic subunits began being referred to as the 
Telomerase Reverse Transcriptase (TERT) family of proteins [37]. 
The budding yeast, S. cerevisiae, has been an enlightening model system for 
examining telomerase action at a molecular level.  Benefits of using this organism 
include the ease and variety of genetic manipulation since the genome has been 
sequenced, the rapid growth rate, detectible telomerase activity each cell cycle, and 
functional conservation of general mechanisms to other organisms.    
 
The Saccharomyces cerevisiae telomerase complex 
  
Identification of complex components 
 In 1989, Drs. Victoria Lundblad and Jack Szostak designed a yeast genetic screen 
to identify genes compromised for telomere maintenance in S. cerevisiae.  Since a 
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telomere length defect is a difficult phenotype for which to screen, their study exploited 
the plasmid linearization assay previously used by Drs. Blackburn and Szostak [21].  
They theorized that any mutant defective in telomerase activity would be unable to 
extend the Tetrahymena telomere repeats when introduced into S. cerevisiae and would 
result in loss of the linear DNA molecule.  After randomly mutagenizing the yeast 
background, a gene was isolated that failed to maintain the linearized DNA, exhibited 
shortened chromosomal telomeres, and displayed a senescence phenotype associated with 
telomere shortening over time.  This newly identified and cloned gene was named EST1, 
for Ever Shorter Telomeres [38].  A second, larger screen from Dr. Lundblad’s lab 
identified three additional genes: EST2, EST3, and EST4 (later determined to be a 
separation-of-function allele of CDC13) [33,39].   
 Since telomerase is a ribonucleoprotein [24] and the RNA component had 
previously been identified in Tetrahymena [25], researchers worked on identifying the 
RNA component in S. cerevisiae.  It had been discovered that genes lying in close 
proximity to telomeres were transcriptionally repressed, a phenomenon called the 
telomere position effect (TPE) [40].  Screening for overexpression suppressors of TPE 
using a genetic library, Drs. Miriam Singer and Daniel Gottschling identified one gene 
that specifically repressed telomere silencing but did not affect silencing at other loci.  
They called this gene TLC1, for Telomerase Component 1.  Intriguingly, they noticed that 
TCL1 did not contain a long open reading frame (ORF) and hypothesized that the 
functional product was the RNA itself.  Additionally, examination of the gene sequence 
revealed a 16-nucleotide (nt) segment that matched the S. cerevisiae telomere [22], 
suggesting this may be the templateing RNA.  They confirmed their theory by 
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demonstrating that mutations within this region were incorporated into newly synthesized 
native telomeres [41], as had been previously demonstrated with the Tetrahymena RNA 
component [25,26].   
 
Functional characterization of each subunit  
 With the identification of genes that affected telomere maintenance and 
hypothesized to be components of the telomerase enzyme complex [33,38,41], S. 
cerevisiae as a model system for telomerase was fully established.  Work then shifted 
toward determining the functional role of each subunit and the conservation of these 
functions across a diverse range of taxa. 
 
 Telomerase RNA (TLC1) 
 Telomerase reverse-transcribes a TERC (telomerase RNA component) to 
synthesize telomere repeats (Figure 2).  In S. cerevisiae, this RNA molecule is called 
TLC1 but homologs in other organisms are referred to simply as TR, for telomerase 
RNA.  The TR has been identified in 28 ciliates, 14 yeasts, and 43 vertebrates [42].  
While TERCs across taxa share similarity in their template region, the size and sequence 
of the molecules vary substantially.  In ciliates, the RNA is ~150 nt long, ~500 nt in 
vertebrates and ~1,300 nt in yeasts [25,30,41-45].  Even with this challenge, secondary 
structure similarities can be identified.  For accurate telomere synthesis, the RNA must 
base-pair correctly with the telomere primer and have a defined template boundary.  All 
TRs create this boundary with a 5’ long-range base pairing element and a 3’ pseudoknot   
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Figure 3.  Multiple proteins bind the S. cerevisiae telomerase RNA molecule, TLC1. 
TLC1 RNA folds into secondary structures that create separate binding sites for multiple 
proteins.  The catalytic subunit, Est2p, associates with the pseudoknot structure located 
near the template (in yellow).  Est1p and the yKu heterodimer associate with stem-loops 
on separate arms.  Est3p does not bind directly to the RNA, but interacts with both Est1p 
and Est2p through protein-protein interactions.  The 7-member Sm-complex associates 
with the sequence –AAUUUUG—located near the 3’ terminus.  The template boundaries 
are defined by the 3’ pseudoknot structure and the 5’ duplex at the base of the yKu arm.  
These structures help with alignment of the template-RNA and prevent run-through 
reverse transcription. 
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structure (Figure 3).  These elements ensure proper alignment with the DNA and efficient 
polymerization and translocation of the catalytic core (reviewed in [45]).  Following 
transcription by RNA Polymerase II, TLC1 RNA is polyadenylated and gets a 5’-
trimethylguanosine (TMG) cap to produce the mature form of the molecule.  The 7-
member Sm protein complex binds in a heptameric ring-shape around a site located near 
the 3’ end of the RNA and is required for RNA stability and complete maturation (Figure 
3).  A strain lacking the Sm-binding site demonstrates a growth defect, short telomeres, 
and near background levels of the mature TLC1 RNA.  Finally, immunoprecipitation of 
an Sm protein can co-immunoprecipitate functional telomerase as measured by an in vitro 
primer extension assay, arguing that the Sm-protein bound form of TCL1 RNA is 
enzymatically active [46]. 
TLC1 RNA acts as a flexible scaffold, providing multiple protein binding sites 
(Figure 3) [47].  Est2p, the reverse transcriptase, binds to the central core containing the 
template region [48-50].  Est1p, an accessory protein described in more detail below, 
binds a sub-helix [51,52].  The yKu heterodimer binds the TLC1 RNA through a 48 nt 
stem-loop; this interaction is necessary for proper intracellular location and efficient 
recruitment of telomerase to telomeres [53-55].   
The full length TLC1 RNA is not functional when in vitro transcribed in rabbit 
reticulocyte lysate (RRL) most likely because it is unable to fold correctly.  This 
characteristic has created obstacles for scientists interested in using biochemical assays to 
investigate telomerase complex assembly and reconstitute telomerase activity in vitro.  
Largely due to this technical limitation, studies of telomerase in S. cerevisiae have relied 
heavily upon genetic strategies as compared to studies in ciliates, which have used almost 
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exclusively biochemical approaches [25,33,38,41,56-58].  To combat this folding issue, 
miniature telomere RNA (Mini-T) versions have been produced.  In these cases, the 
“extraneous” sequences between protein binding sites have been removed, reducing the 
molecule’s size to 384 or 500 nt.  Both of these Mini-T versions support some telomere 
maintenance in vivo and reconstitute telomerase activity in vitro when produced in RRL.  
However, these versions do not maintain wild-type telomere length nor robust cell 
growth, indicating that the yeast TLC1 RNA has evolved to be a larger size for maximum 
efficiency [50].  An even smaller variant, called the Micro-T, contains only the template 
and pseudoknot in a 170 nt RNA.  Micro-T is active in vitro when combined with Est2p 
[59].  Recently, a 956 nt variant called the triple-stiff-arm TLC1 (TSA-T) was introduced.  
TSA-T removes the secondary structures (bulges and loops) from the long arms 
separating the binding sites for yKu, Est2p, Est1p and Sm proteins, replacing them with 
“stiffened” duplex RNA sequences.  Since this approach maintains the relative spacing 
between the binding sites, the authors were interested in whether the TLC1 RNA requires 
flexibility to support telomerase function.  They found that the TSA-T variant was 
functional both in vitro and in vivo, maintaining telomeres even better than the wild-type 
TLC1.  The authors then stiffened one arm at a time and found that the stiffened Est1p 
and yKu arms contribute to telomere lengthening while the stiffened Sm arm reduced 
telomere length (but not as severely as the Mini-T) and RNA abundance.  The remarkable 
malleability of the RNA is consistent with the idea that the RNA serves only as a tether 
and is not required to position the proteins in a specific way relative to each other [60].   
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Telomerase Catalytic Subunit (EST2) 
 The S. cerevisiae TERT subunit is encoded by EST2.  Est2p, a 102 kDa protein 
discovered in the 1996 screen described above [33], shows conservation of both sequence  
and function across taxa.  These conserved regions are grouped into the N-terminal 
domain, reverse transcriptase (RT) domain, and the C-terminal extension (CTE) domain 
(Figure 4).  Within the RT domain, several motifs (1, 2, A, B’, C, D, E) are universally 
conserved among RTs; the N and C-terminal domains are specific to telomerase 
(reviewed in [45]).   
 The N-terminal domain is comprised of four regions [61].  Region I, also 
called the telomerase essential N-terminal (TEN) domain, is important for telomerase 
complex assembly (Figure 4).  Temperature sensitive (ts) mutations in this region can be 
suppressed by the overexpression of Est3p and a lethal mutant in the region loses the 
ability to co-immunoprecipitate Est3p, suggesting that the TEN domain may function to 
recruit Est3p to the complex [62].  Indeed, Dr. Jennell Talley, a recent graduate of our 
lab, showed that the Est2p TEN domain and Est3p interact directly and that this 
interaction stimulates telomerase activity in vitro [63].  Likewise, in Candida 
parapsilosis and Lodderomyces elongisporus, Est3p directly interacts with the TEN 
domain of TERT in vitro.  This interaction also facilitates Est3p binding to telomeric 
DNA, suggesting that the TEN-Est3p interaction unmasks a DNA binding activity in 
Est3p [64].   The N-terminal domain is important for TLC1 RNA binding [65] and 
telomere DNA binding [66-68].  Dr. Robin Bairley, a recent graduate of our lab, 
confirmed that the anchor site lies in the TEN domain of Est2p and that a mutation in this       
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Figure 4. Functional domains of EST2 and EST1. 
The S. cerevisiae EST2 gene encodes the reverse-transcriptase (RT) subunit of 
telomerase.  The domain motifs (1, 2, A, B’, C, D, E) are universally conserved amongst 
RTs.  The IFD (insertion in finger domain) and the N and C-terminal extensions are 
specific to telomerase.  The EST1 gene encodes the telomerase recruitment protein, 
Est1p.  The region of highest homology across species includes the TPR-consensus 
sequences.  Est1p binds nucleotides (RNA and DNA) in an overlapping region near the 
C-terminus.  Also within this region are the residues important for G-quadruplex 
formation activity. 
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domain (E76K) enhances the binding affinity of the TEN domain for telomeric DNA and 
alters the telomere-RNA alignment [69]. 
 The RT domain is the catalytic center of telomerase (Figure 4) (reviewed in [45]).  
Three conserved aspartic acid residues in motifs A and C are essential for RT activity.  
These residues lie in the active site of the enzyme and coordinate two magnesium ions, 
defining the nucleotide-binding pocket that orients correct nucleotides for incorporation 
[70].  In S. cerevisiae, specific residues in motif C and E of the RT influence nucleotide 
addition processivity (NAP; Figure 2), the ability to incorporate each successive base 
onto the telomere end [71].  Repeat addition processivity (RAP; Figure 2), the ability to 
synthesize multiple repeats on the same telomere without dissociating, is compromised 
when mutations are made in the telomerase specific insertion in finger domain (IFD) 
which lies in the RT domain between motifs A and B’ (Figure 4) [72].  
 The CTE domain exhibits weak conservation but mutations in this domain affect 
telomerase processivity [73,74].  While the domain is essential in TERTs of some 
species, such as humans and Tetrahymena, the region is dispensable for telomerase 
activity in S. cerevisiae [61,75].  In mammalian telomerase, the CTE domain may also 
influence telomerase multimerization and provide binding sites for the 14-3-3 and CRM1 
proteins that regulate the localization of the TERT protein [76-79]. 
 
Telomerase Accessory Protein (EST3) 
 The S. cerevisiae accessory protein, Est3p, is the smallest (19 kDa) integral 
component of telomerase.  This subunit is essential for telomerase function in vivo but is 
dispensable for activity in vitro, suggesting it is a regulatory or accessory protein.  It was 
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first identified in the genetic screen that identified Est2p-Est4p [33] but has remained an 
enigma until recently.  S. cerevisiae EST3 encodes two ORFs that must undergo a 
programmed +1 translational shift to produce full length Est3p.  At steady state, the 
frameshifted peptide is estimated to represent 75-90% of the total Est3 protein pool [80].  
S. cerevisiae Est3p is recruited to the telomerase complex through a direct interaction 
with the catalytic subunit, Est2p, and recruitment subunit, Est1p (Figure 3) [63,81]. There 
have been no Est3 proteins identified outside of budding yeast.  However, using structure 
prediction programs, Est3p is predicted to exhibit an oligonucleotide/oligosaccharide-
binding (OB) fold with similarity to the mammalian shelterin component TPP1 [82,83].  
TPP1 binds to the C-terminus of POT1, a ssDNA binding protein, and facilitates its 
recruitment to the telomere where it functions to protect the end of the chromosome from 
degradation or fusion events [84-86].  TPP1 is also a telomerase processivity factor, 
stimulating telomere repeat addition in vitro [87,88] and stimulating recruitment of 
telomerase in vivo [89-91].  Est3p was reported to increase the repeat addition 
processivity of telomerase in Saccharomyces castelli, a close relative to S. cerevisiae [92], 
consistent with the suggestion that Est3p may be a homolog of TPP1. S. cerevisiae Est3p 
also stimulates telomerase activity in vitro, although these experiments were done under 
conditions that did not measure processivity [63].  These results continue to support the 
prevailing notion that Est3p is structurally and functionally related to TPP1.  These 
studies are beginning to tease apart the function of Est3p in the telomerase complex.     
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Telomerase Recruitment Protein (EST1) 
 S. cerevisiae EST1 encodes a highly basic 81 kDa protein that was the first 
telomerase component cloned in yeast [38].  Like Est3p, Est1p is not required for in vitro 
telomerase activity but is necessary for in vivo activity.  Sequence alignment of Est1p 
homologs across species revealed a conserved tetratricopeptide repeat (TPR) in the N-
terminus of the molecule (Figure 4).  TPR domains are often involved in protein-protein 
interactions and several EST1 mutants that map to this region are defective for assembly 
with the complex [93].  Est1p recruits telomerase to the telomere through its direct 
interaction with the ssDNA binding protein Cdc13p.  Est1p exhibits three biochemical 
activities: interaction with single-stranded telomeric DNA, association with TLC1 RNA, 
and interaction with the ssDNA binding protein Cdc13p (Figure 4). 
 Titrating purified Est1 protein into an in vitro telomerase extension assay 
stimulates telomerase activity, in a manner similar to that observed with Est3p [94].  
Est1p binds directly to the TLC1 RNA through three secondary structural elements within 
the sub-helix IVc: a pentanucleotide bulge, an adjacent internal loop, and a single-
stranded region at the base of the sub-helix (Figure 3) [51,52].  Interestingly, when the 
stimulation assay was performed in the presence of TLC1 molecules lacking this 
structural element, the stimulation of telomerase activity was unchanged.  This result 
suggests that telomerase activity is only partially dependent upon Est1p binding to TLC1 
RNA and that other, possibly protein-protein, interactions are important for stimulating 
activity [94].  It was reported that Est1p exhibits weak but specific affinity for single-
stranded telomeric DNA.  This DNA binding activity maps to a 130 amino-acid (aa) 
region in the C-terminus of the protein (Figure 4) and requires a free 3’ terminus, 
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suggesting that it specifically mediates the recognition of chromosome ends [95].  
However, stimulation of in vitro activity was not affected when DNA molecules lacking a 
sufficient 3’ overhang for Est1p interaction were used.  Est1p stimulated the DNA 
extension irrespective of when telomerase was assembled with the DNA, suggesting that 
Est1p does not bind to telomeres during DNA extension, but instead tethers the DNA 
bound telomerase and modulates overall enzymatic activity independent of direct DNA 
binding [94].    
 The primary regulatory role for Est1p is to recruit telomerase to the site of action.  
This recruitment function is accomplished through the direct protein-protein interaction 
between Est1p and the ssDNA binding protein Cdc13p [96-100].  As a test of this model, 
telomerase was recruited to non-telomeric sites using a Cdc13p-Est1p fusion construct.  
This construct was able to relocalize the catalytic subunit, Est2p, leading to the 
conclusion that Est1p exhibits a recruitment function and does not merely activate the 
complex by binding [98].  Est1p’s recruitment function can be bypassed by tethering the 
enzyme to the telomere through expression of a Cdc13p-Est2p fusion construct.  In this 
context, cells can survive without EST1 but die if EST3 is deleted, providing additional 
evidence for this recruitment model and further suggesting that Est3p has function(s) 
other than recruitment.  When the Cdc13p-Est2p fusion is expressed in a wild-type 
background, telomeres get substantially longer due to excessive recruitment of the 
telomerase complex to telomeres.  Although deletion of Est1p is tolerated in cells 
expressing the fusion protein, telomere overelongation is not observed.  This result 
suggests that Est1p has a function independent from recruitment.  One possibility is that 
Est1p stimulates the recruitment of Est3p into the complex.  Consistent with this idea, 
  
 
23 
Est1p and Est3p directly interact in vitro [81].  Additionally, this hypothesis is consistent 
with work from a previous student in the Friedman laboratory, Dr. Jennifer Osterhage.  
She found that overexpression of Est1p resulted in an increased association of Est3p in 
the telomerase complex.  She went on to demonstrate that Est1p is both necessary and 
sufficient for Est3p recruitment to the telomerase complex [101].  
G-quadruplexes are known to form at telomeres because the telomeric sequence is 
highly guanine-rich.  These structures are formed from G-quartets, four guanines 
arranged into a cyclic orientation.  These G-quartets can then stack on top of each other 
to result in a G-quadruplex structure that is stabilized with a potassium or sodium ion in 
the central core (reviewed in [102]).  Est1p has been implicated in the induction of G-
quadruplex formation in vitro.  This activity maps to a region near the C-terminus of the 
protein and overlaps with the region involved in DNA binding (Figure 4).  Mutations that 
disrupt this function exhibit cellular senescence in vivo, suggesting that G-quadruplex 
formation is a positive regulator of telomerase activity.  Consistent with the hypothesis 
that Est1p activates telomere-associated telomerase [103], Est1p can unwind DNA-RNA 
heteroduplexes and concomitantly produce G-quadruplexes [104].  Furthermore, fusion 
of Est1p, but not Est2p, to Cdc13p can rescue the ts phenotype of yku80∆, important for 
chromosome capping, suggesting a role for Est1p in the protection of telomeres [105].  In 
support of this role, the Est1p homolog in humans, hEST1A, has been implicated in the 
protection of chromosome ends [106].  Both unwinding and telomere protection are 
compromised by mutations that affect G-quadruplex formation [104,105].  These studies 
suggest a model for the function of Est1p-dependent G-quadruplex formation:  Est2p is 
telomere-associated through an interaction with the TLC1 RNA and yKu heterodimer 
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(see “Cell Cycle Regulated Assembly and Recruitment of Yeast Telomerase”) [54], Est1p 
binds to the telomere end and unwinds the TLC1 RNA-DNA heteroduplex, causing 
dissociation of the Est2p-TLC1 complex.  Est1p then forms G-quadruplex from the G-
rich ssDNA, simultaneously protecting the telomere end from recombination events and 
facilitating telomerase recruitment/activation at the terminal 3’ end [104,105]. 
 
Regulation of Yeast Telomeres  
 
Telomere structure 
 Unlike human telomeres that are composed of perfect repeats, S. cerevisiae 
telomeres are made up of degenerate repeats with a consensus sequence G2-3(TG)1-6, but 
simply referred to as G1-3T.  The sequence heterogeneity arises from use of the template 
sequence 3’-484ACACACACCCACACCAC468-5’.  Since a DNA substrate that ends in a 
TG has multiple possibilities for alignment, the number and sequence of nucleotides that 
telomerase synthesizes each round can, and most likely will, vary.  Additionally, the 
probability of incorporation decreases as synthesis reaches the 5’ boundary of the 
template.  For example, there is only a 53% chance of copying the 471CC470 di-nucleotide 
located near the end of the template [107,108].  Nucleolytic degradation and the continual 
ebb and flow resulting from the end-replication problem in combination with telomerase 
activity may also influence the heterogeneity of the telomere sequence and keep the distal 
portion of the telomere highly dynamic.  
 S. cerevisiae telomeres contain sub-telomeric repeats located immediately 
centromeric to the G-rich tract.  This region is composed of repetitive sequences called X 
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and Y’ elements.  All chromosomes have an X element, while ~50-65% of chromosomes 
have one or more Y’ elements separated by G1-3T sequence.  While these elements are 
not conserved even within closely related species, they are a useful readout for 
telomerase-independent telomere maintenance because the Y’ elements are amplified 
during such time.  This phenomenon will be discussed in the following section. 
 To date, all telomeres examined end with a single-stranded 3’-overhang of the G-
rich strand, called the G-tail.  However, the mechanism through which the overhang is 
generated is incompletely understood (reviewed in [109]).  This structure is critical for 
cell survival and is thus under strict regulation to ensure its fidelity.  In S. cerevisiae, this 
G-tail is short (12-14 nt) throughout the cell cycle.  During DNA replication, the lagging 
strand contains an overhang upon removal of the terminal RNA primer but the leading 
strand is blunt ended.  Following passage of the replication fork in late S phase, the 3’-
overhangs on both leading and lagging telomeres are transiently increased in length 
[110,111].  This transient elongation is due to exonucleolytic digestion of the 5’-strand 
[17,110,112].  This resection is dependent upon the MRX (Mre11p-Rad50p-Xrs2p) 
complex in yeast [111,113].  However, this 5’ resection of the C-strand utilizes a 
redundant mechanism, as G-tails are shorter but not eliminated in the absence of MRE11, 
the exonuclease of the MRX complex [111].  Telomeric C-strand resection is also 
dependent upon Sgs1p, a member of the RecQ DNA helicase family; Sae2p, an 
endonuclease that undergoes cyclin-dependent kinase (CDK) phosphorylation critical for 
activity; the exonuclease Exo1p; and the nuclease/helicase Dna2p that is involved in long 
flap processing during removal of the RNA/DNA primers in Okazaki fragments [114-
117].  Consistent with these findings, passage of the replication fork, the completion of S 
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phase, and CDK activity were previously implicated as being necessary for 3’ overhang 
formation at both native and de novo telomeres [111,112,118,119].  In the absence of 
both SAE2 and SGS1, C-strand resection was nearly undetectable, suggesting that these 
two proteins work in separate but redundant pathways involved in overhang formation.  
Exo1p and Dna2p acquire access to the telomere after the initiation by Sae2p or Sgs1p 
[117].  Therefore, the resection of telomeric 5’ strands involves several redundant 
pathways to ensure proper formation.  
 
Protection of chromosome ends 
 As discussed above, the telomere end exists as a single stranded 3’-overhang 
throughout the cell cycle.  There are several proteins that are necessary for capping the 
telomere and ensuring the fidelity of the chromosome end.  Loss of these factors can 
result in telomere uncapping and expose the termini to unregulated resection and/or 
catastrophic chromosome end-to-end fusions.  As discussed above, the Est1 protein has 
been implicated in the protection of chromosome ends.  Here is a discussion of two 
additional pathways of telomere protection. 
 In yeast, the 3’-overhang is bound by the ssDNA binding protein Cdc13p in a 
sequence-specific manner.  Cdc13p contributes to both telomere capping and telomerase 
recruitment through its interaction with Est1p.  It is essential for protecting the 
chromosome termini from degradation; loss of CDC13 function results in excessive 
resection of the 5’ strand, resulting in a Rad9p-mediated cell cycle arrest.  Cdc13p is a 
component of the CST protein complex along with Stn1p and Ten1p.  The Stn1 protein 
was found as a suppressor of the cdc13-1 temperature sensitive (ts) allele and Ten1p was 
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identified by its ability to rescue the ts phenotype of stn1-13 [120,121].  Like with 
Cdc13p, a defect in either TEN1 or STN1 results in a Rad9p-dependent arrest.  Stn1p and 
Ten1p may also act independently from Cdc13p since overexpression of these two 
components can suppress the lethality of a CDC13 deletion [122-124].  Cdc13p interacts 
with the telomeric 3’ overhang through a single OB fold, called the DNA-binding domain 
(DBD), located between residues 497 and 694 of the 924 aa protein [125,126].  This 
domain is structurally similar to another ssDNA binding protein found in S. pombe and 
many other higher eukaryotes, POT1 [84,125].  As introduced above, POT1 is a binding 
partner with TPP1, a potential homolog to Est3p.  Stn1p’s N-terminal domain interacts 
with Ten1p while the C-terminal domain interacts with Cdc13p [127].  The CST complex 
plays the primary telomere capping function in S. cerevisiae. 
 Although one of the main functions of telomeres is to prevent non-homologous 
end-joining (NHEJ) of chromosomal ends, the main effector of this pathway, Ku, also 
surprisingly binds to telomeres.  The yKu heterodimer, consisting of a 70 kDa and 80 
kDa subunits, binds with high affinity to dsDNA ends in a sequence-independent manner 
[128].  yKu binds the telomere end to serve as a protective cap and also binds directly to 
the telomerase RNA molecule.  It binds to the extreme terminus, near the double-single 
stranded junction.  The heterodimer is constitutively associated with telomeres and binds 
in a ring-like shape, threading the DNA through the channel.  In the absence of yKu 
function, the ssDNA 3’-overhang is much longer than normal, suggesting that yKu is 
important for telomere end protection, even in the presence of a wild type CST complex.  
This elongation of the ssDNA is due to increased nucleolytic digestion of the 5’ strand 
since deletion of the exonuclease Exo1p results in a partial rescue.  Increased temperature 
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exacerbates this resection phenotype.  These results clearly suggest that yKu is important 
for preventing nuclease attack of the telomeric end.  Additionally, separation-of-function 
alleles of yKu that impart compromised end-structure but are unaffected for TLC1 
binding have been identified.  Therefore, yKu exhibits three functional roles: TLC1 
interaction, telomere protection, and repair of double-strand breaks. 
 
Telomere length homeostasis 
 Stable telomere length is governed by the balance of activities that generate 
telomeric DNA, such as telomerase, and events that result in telomere loss, such as 
nuclease digestion and semi-conservative replication.  Telomere length is regulated in 
part by several proteins that interact with the telomere and influence telomerase activity.  
S. cerevisiae Rap1p binds to double-stranded telomeric DNA via two tandem myb-like 
DNA-binding domains.  While bound to telomeres, Rap1p enhances telomeric silencing 
and negatively regulates telomere length through its C-terminus.  Regulation by Rap1p is 
essentially a counting mechanism to determine if the telomere is in need of elongation.  
The laboratory of Dr. David Shore illustrated this function by inserting an 80 bp 
telomeric tract upstream of a native telomere.  Even though a 40 bp linker separated this 
inserted sequence from the normal telomere, the native telomere shortened, suggesting 
that the newly inserted sequence was being “counted” as part of the whole telomere.  
Inversion of this inserted DNA resulted in the native terminal telomere being elongated, 
consistent with a requirement for correct orientation.  Since it was known that Rap1p 
binds to telomere duplexes, the authors asked whether this protein was playing a role in 
telomere length regulation.  Either Rap1p or its C-terminus alone was artificially tethered 
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(via the Gal4 DNA binding domain) to an area adjacent to the telomere tract.  Once 
again, the native telomere shortened to an extent proportional to the number of Rap1p 
molecules present.  This work demonstrated that Rap1p molecules are “counted” to 
determine the length of the telomere.  When the telomere is long, many Rap1p binding 
sites are bound and telomerase does not extend this chromosome end [129].  Two 
proteins, Rif1p and Rif2p, interact with the Rap1p C-terminus.  In fact, tethering these 
two proteins to telomeres (as done with Rap1p) also shortens telomeres.  Therefore, while 
Rap1p is bound to the telomere itself, the effectors of this negative feedback loop are its 
C-terminal binding partners Rif1p and Rif2p.  
  While the negative feedback loop involving Rap1p was established, it remained 
unresolved if the regulation was achieved by modulating the probability with which 
telomerase initiates synthesis or by regulating the extent to which telomerase acts once 
elongation begins.  To investigate this question, a new method was developed that allows 
the monitoring of telomeres within a single cell cycle.  This single telomere extension 
(STEX) assay method provided insight into both the frequency and extent of telomere 
addition.  After monitoring the number of individual telomeres that are extended and the 
number of nucleotides that are added, the Lingner lab established that only ~10% of 
telomeres get elongated in a single cell cycle.  The amount of addition occurring at 
different telomeres was quite varied and was, for the most part, independent of telomere 
length.  However, the probability of telomere elongation was inversely proportional to the 
beginning length of the telomere.  Deletion of either RIF1 or RIF2, important for the 
negative feedback loop described above, resulted in a larger percentage of telomeres 
being elongated in a single cell cycle [130].  This observation suggests that telomerase is 
  
 
30 
regulated at the initiation point, with telomeres existing in an extendable or non-
extendable state.  
The shortest telomeres are preferentially and more extensively elongated by 
telomerase.  To elucidate the reason for this extensive elongation, a modified STEX assay 
was developed to allow monitoring of telomerase repeat addition processivity in vivo.  
This assay used cells expressing two different TLC1 template molecules.  Incorporation 
of a string of one type of template sequence demonstrated processivity, while an 
interspersion of the two templates would indicate synthesis by non-processive enzymes.  
Using this assay, it was determined that telomerase is non-processive at most wild-type 
telomeres, but switches to a processive mode of synthesis on critically short telomeres, 
resulting in extensive telomere elongation.  Tel1p kinase, the S. cerevisiae ATM ortholog 
involved in the DNA damage response, is required for this enhancement of processivity 
at critically short telomeres [131].  It remains unclear how Tel1p exerts this affect on 
processivity. 
 In the absence of Rif1p or Rif2p, telomeres over-elongate in a Tel1p-dependent 
manner, suggesting Tel1p plays a positive role in telomere length regulation [132].  In 
support of this role, Tel1p specifically associates with short telomeres in a manner 
dependent upon the C-terminus of Xrs2, a component of the MRX complex involved in 
DNA damage repair.  In the absence of Rif2p, Tel1p no longer shows a preference for 
short telomeres [133], suggesting low Rif2p levels mark short telomeres for elongation.  
Additionally, preferential association of the telomerase subunits Est2p and Est1p with 
short telomeres is Tel1p-dependent [134].  Together, these data are consistent with the 
following model for preferential elongation of short telomeres (Figure 5): 1) as telomeres  
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Figure 5.  Cell cycle regulated recruitment of telomerase. 
In G1 phase, the catalytic subunit Est2p associates with the telomere in a manner that 
requires the TLC1-yKu interaction.  While the exact mechanism remains unclear, it is 
hypothesized to involve a handing off of yKu from TLC1 to the telomere, since yKu is 
unable to bind the RNA and DNA simultaneously.  During this time, Est1p undergoes 
proteasome-dependent degradation, preventing Est3p assembly with the complex.  
Following replication in S phase, the 3’ overhang is elongated by resection of the 5’ 
strand by MRX, Sgs1p, Sae2p, Exo1p, and Dna2p (not shown for simplicity).  The 
shortest telomeres have a decreased amount of Rif2p, which is sensed by Tel1p, marking 
these ends for elongation.  This elongation of the 3’ overhang allows additional CST 
(Cdc13p-Stn1p-Ten1p)-complex association, which recruits the telomerase complex 
through the direct interaction between Cdc13p and Est1p.  Following telomere elongation 
by telomerase, the lagging-strand replication machinery inhibits telomerase and fills in 
the gap.    
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shorten, the Rap1p/Rif2p concentration decreases and allows the MRX complex to 
associate with telomeres, 2) Tel1p is recruited to these short telomeres and 
phosphorylates some telomere protein (possibly Cdc13p [135]), and 3) telomerase is 
recruited and actively elongates the telomere.   
 
Cell cycle regulated assembly and recruitment of yeast telomerase 
 Telomerase is able to synthesize telomeric repeats at a double-strand break that is 
induced adjacent to a telomeric seed when the cells are arrested in G2/M phase but not 
when arrested in G1 phase [136].  Additionally, a telomere that has been artificially 
shortened through an induced recombination event is not elongated when cells are 
arrested in G1 phase but is elongated during late S/G2 phase [137].  These two studies 
showed that telomerase activity is restricted to a window of time from late S phase 
through G2/M phase, suggesting there are mechanism(s) in place to prevent it from 
elongating telomeres at other times.  Consistent with this, CDK activity (which is very 
low in G1 phase) and passage of the replication fork are associated with telomerase 
addition [118,119,136].  As described above, the telomere end structure changes through 
the cell cycle (Figure 5).  After passage of the replication fork, the short single-stranded 
3’-overhang (G-tail) gets longer due to exonuclease activity on the complementing 5’-
strand (Figure 5) [17,112,118,119].  This lengthening of the ssDNA portion of the 
telomere exposes additional binding sites for Cdc13p, as it requires as little as 11 nt to 
bind efficiently [39,138,139].  Since Est1p binds directly to Cdc13p and Est2p, this 
increased association to the telomere recruits the telomerase complex [81,96-100].  The 
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mechanism(s) of temporal regulation on yeast telomerase intrigued researchers and much 
effort has been expended toward understanding it. 
Utilizing chromatin immunoprecipitation (ChIP) experiments to examine the 
temporal association of telomerase components with the telomere, it became apparent 
that these telomere proteins exhibit cell-phase specific binding patterns.  Cdc13p is 
associates with the telomere throughout the cell cycle but its binding increases 
dramatically during late S phase, which is expected as the G-tails are longer (Figure 5) 
[103].  The telomerase subunit Est1p and Est3p associate solely in late S/G2 phases 
[81,103].  However, it was the catalytic subunit that was the most intriguing.  Est2p 
exhibits biphasic binding to the telomere during late S/G2 as well as in G1 phase, when 
telomerase is inactive in vivo [103].  The two peaks of binding are a result of two modes 
of Est2p recruitment to the telomeres.   
During G1 phase, Est2p and TLC1 RNA are located at the telomere through an 
interaction with the yKu heterodimer [54].  However, because yKu is unable to 
simultaneously bind DNA and RNA in vitro, the dependence upon yKu for this 
positioning is hypothesized to be due to yKu associating with TLC1 RNA and then 
handing it off to bind to the telomere, for which it has a higher affinity [55].  Est1 protein 
levels are very low during G1 phase, preventing its association with the telomere (Figure 
5) [101,103].  However, Est1p levels stabilize as cells proceed into late S phase, when 
telomeres are replicated, and can now associate with the telomere due to its direct 
interaction with Cdc13p, also peaking at this time [100,101,103,137].  The concomitant 
association of Est1 and Est3 proteins with the telomere supports the finding that Est1p is 
necessary and sufficient for Est3p recruitment into the complex (Figure 5) [81,103].  
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Since the stabilization of Est1 protein levels with the proteasome inhibitor MG132 did 
not result in telomere addition during G1 phase [101], regulated degradation is not the 
entire reason telomerase is inactive at this time.  There must be an additional mechanism 
that restricts telomerase activity to late S/G2 phase.  The work in this thesis will be 
focused on the mechanism that targets Est1p for degradation during G1 phase. 
 
Telomerase-independent telomere maintenance 
 In a last ditch effort to maintain telomere lengths that have become critically short 
due to some deficiency in telomerase activity, a small percentage of an S. cerevisiae 
population will switch to an alternative lengthening of telomeres (ALT) mechanism.  The 
ALT pathway utilizes homologous recombination to extend telomeres, and can therefore 
be inhibited by deletion of the central recombination gene RAD52.  Cells that have 
switched to an ALT pathway are termed “survivors”, for they survived the senescence 
fate of their brethren.  There are two types of RAD52-dependent pathways that yield 
survivors: Type I and Type II events.  Type I survivors have amplified their Y’ elements 
(both the long and short forms) or spread them to chromosomes where Y’ elements were 
previously lacking.  Intriguingly, a very short terminal telomere tract remains present, but 
the mechanism of its maintenance remains unresolved.  It is possible that a strand 
invasion from a shorter telomere into a longer telomere could be followed by DNA 
synthesis, using the telomere tracts as a template.  Type II survivors have undergone 
rolling-circle replication, which leads to substantial lengthening of their telomeres.  Type 
II survivors arise much more slowly in the population, but grow faster than Type I once 
established.  Therefore, in liquid culture, Type II survivors tend to out-compete Type I 
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survivors.  It is also common for survivor clones to exhibit a mixture of Type I and II 
survivor traits (reviewed in [140]).   
 
Protein Degradation 
 Within a cell, protein levels are determined by the rates of synthesis and turnover.  
Selective proteolysis is important for sustaining normal cellular processes.  In yeast, the 
lysosome/vacuole and the proteasome are the two major pathways involved in protein 
degradation.  Lysosomes contain a variety of enzymes that degrade proteins and other 
molecules delivered by endocytosis, phagocytosis, or autophagy.  Nevertheless, the 
majority of short-lived proteins are degraded by the proteasome after being post-
translationally modified with ubiquitin.  In eukaryotes, the ubiquitin-proteasome pathway 
(UPP) is essential for many fundamental cellular processes, such as cell cycle progression, 
protein quality control, DNA repair, and signal transduction.   
 
The ubiquitin-proteasome pathway  
 In 1975, an 8.5 kDa polypeptide was isolated from bovine thymus and found to be 
expressed in many other tissues and organisms, including guinea pig, mouse, chicken, 
fish, plants, and fungi.  The widespread expression profile and the original finding that 
this peptide stimulated differentiation of thymocytes and the activity of adenyl cyclase 
(though these functions were later debunked) led this protein to be called UBIP, for 
ubiquitous immunopoietic polypeptide [141], or ubiquitin.   
 In 1953, Dr. Melvin Simpson showed that proteolysis requires energy but the 
reason remained unclear [142].  In the late 1970’s, research from Dr. Avram Hershko, his 
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graduate student Dr. Aaron Ciechanover, and collaborator Dr. Irwin Rose showed that 
proteolysis in rabbit reticulocyte lysate (RRL) required a heat-stable polypeptide they 
named APF-1 (ATP-dependent proteolysis factor 1) in addition to a crude fraction of 
high molecular-weight (now known to contain the proteasome, see below) [143,144].   
 125I-labeled APF-1 was converted to a higher molecular weight in an Mg2+ and 
ATP-dependent manner when incubated with the crude fraction.  Additionally, this 
linkage was stable and covalent since it survived high pH and denaturation with 0.1 M 
NaOH.  Examination of these higher species by SDS-PAGE revealed that APF-1 was 
conjugated to many different proteins [145].  APF-1 was subsequently identified as 
ubiquitin [146].  To show that this covalent attachment of ubiquitin was related to 
proteolysis, the authors showed that they could detect covalent attachment to various 
degradable proteins, such as lysozyme and globin.  Importantly, they showed that the 
ubiquitin attachment occurs at a lysine residue, multiple ubiquitin attachments can occur 
on a single substrate protein using a processive enzymatic mechanism, and that depletion 
of ATP results in a return to un-modified protein, demonstrating the dynamic nature of 
this attachment [147].  From this work, a model was proposed that is still accurate today: 
ubiquitin is covalently attached to substrate proteins that are then delivered to a specific 
protease (proteasome), resulting in degradation and release of free ubiquitin (via the 
action of deubiquitinating enzymes).   
 Dr. Hershko and colleagues then determined that the mechanism of ubiquitin 
attachment requires the sequential action of three enzymes [148,149].  First, the C-
terminal glycine residue of ubiquitin is activated in an ATP-dependent reaction that 
results in a thiol-ester linkage to a cysteine residue in the active site of the E1 activating 
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enzyme.  This activated ubiquitin is then transferred to a cysteine residue of the E2 
conjugating enzyme.  Finally, the ubiquitin is linked in an iso-peptide bond to a lysine 
residue of a substrate protein specifically bound to an E3 ubiquitin ligase.  This substrate 
linkage can occur via a direct transfer from the E2 or following an additional transfer to a 
cysteine residue of the E3.  By successively adding ubiquitin moieties to the lysine 
residues of previously conjugated ubiquitin molecules, a polyubiquitin chain is formed.  
This chain may then be recognized by the 26S proteasome (reviewed in [150]).  Drs. 
Avram Hershko, Aaron Ciechanover, and Irwin Rose were awarded the Nobel Prize in 
Chemistry in 2004 for their work on the basic functions and mechanism of ubiquitin-
mediated proteolysis. 
 The 26S proteasome, a large cylindrical multi-subunit protein complex found in the 
cytoplasm and nucleus of all eukaryotes, recognizes substrate proteins tagged with 
ubiquitin and subsequently cleaves them into short polypeptide fragments.  The 26S 
proteasome contains a 20S catalytic core particle (CP) composed of 4 rings of 7 subunits 
each, and either one or two 19S regulatory particles (RP) composed of 19 subunits.  The 
19S RP is further divided into a lid and base.  The lid of the 19S RP recognizes 
ubiquitinated substrates and deubiquitinates them.  The base contains ATPase subunits 
that interact with and open the gateway into the 20S CP, bind to and unfold substrate 
proteins, and translocate the substrate into the 20S CP.  The proteolytic active sites are 
located on the inside surface of the 20S CP and consist of chymotrypsin-like, trypsin-like, 
and peptidylglutamyl-peptide hydrolyzing activities.  In summary, the substrate is 
recognized by its ubiquitin chain by the lid, deubiquitinated and bound by protein-protein 
interactions in the base, unfolded, transferred into the 20S catalytic core, proteolytically 
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cleaved at the three protease active sites, and released through the other end as small 
peptides (reviewed in [151]).   
 Temporal regulation of protein destruction is a key aspect of cellular metabolism.  
Some proteins are very long-lived while others are quickly degraded.  In yeast, there is a 
single ubiquitin activating enzyme (E1; Uba1p), thirteen ubiquitin conjugating enzymes 
(E2; Ubc1p-Ubc13p), and over eighty ubiquitin ligases (E3) [152].  The large number of 
E3s determines the exquisite sensitivity of substrate recognition, either alone or in 
conjunction with its partner E2.  Here I will focus on one particular E3 ubiquitin ligase, 
the Anaphase Promoting Complex (APC), which has been studied in detail. 
 
The anaphase promoting complex 
  The APC, also called the cyclosome, is a multi-subunit cullin-RING (really 
interesting new gene) E3 ubiquitin ligase.  The APC is essential for cell cycle 
progression, regulating timely transit through mitosis and entry into S phase.  To achieve 
this precise temporal regulation of the cell cycle, the substrates of the APC must be 
degraded at a specific time.  This pattern of degradation is achieved by regulating both 
the recognition of these substrates and the timing of APC activity.     
 
Subunit composition 
In S. cerevisiae, the APC is composed of 13 core protein subunits (Apc1, Apc2, 
Apc3/Cdc27, Apc4, Apc5, Apc6/Cdc16, Apc8/Cdc23, Apc9, Apc10/Doc1, Apc11, 
Apc13/Swm1, Cdc26, and Mnd2).  Additionally, two substrate specificity factors 
(Cdc20p and Cdh1p) also transiently associate with the complex.  Apc2 (cullin; 
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scaffolding protein) and Apc11 (RING-finger; E2 interacting protein) make up the 
catalytic core of the complex, exhibiting robust in vitro ubiquitination activity but no 
substrate-specificity [153-155].  The majority of the core subunits are essential (8 of 13) 
making their characterization and determination of their arrangement in the complex 
difficult.  To overcome this challenge, Dr. David Toczyski and colleagues engineered a 
yeast strain in which the APC was rendered non-essential.  This strain was generated 
through the deletion of securin/PDS1 and CLB5, and overexpression of the CDK 
inhibitor SIC1.  In strains lacking APC activity, Clb/CDK activity continues to oscillate 
during the cell cycle even though Clb protein levels remain constant.  This argues that 
oscillating Sic1 activity is sufficient to trigger the feedback loops necessary for bi-stable 
Clb/CDK activity.  These results suggested that the APC has two obligatory substrates in 
yeast: securin, whose degradation is required for sister chromosome separation during 
mitosis, and mitotic B-type cyclins (Clb1p-Clb6p) [156].   
 The authors went on to utilize this strain for elucidating the subunit arrangement 
of the complex in vivo.  By deleting subunits singly and monitoring which of the 
remaining subunits still associated, the authors were able to propose an architectural map 
of the S. cerevisiae APC (Figure 6).  The largest subunit, Apc1p, acts as a scaffold 
protein, bridging two sub-complexes.  One sub-complex contains proteins Apc2, Apc11, 
and Apc10/Doc1, with Apc2 independently tethering the other two to Apc1p.  The 
second sub-complex contains the TPR proteins Apc6/Cdc16, Apc8/Cdc23 and 
Apc3/Cdc27, which associate with Apc1 via Apc4 and Apc5.  This work also 
demonstrated that binding of the activator Cdh1p depends upon both Apc2p and 
Apc3/Cdc27p, and an internal motif called the C-box [157].  From other studies, it was  
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Figure 6.  Schematic of the Anaphase Promoting Complex (APC). 
The APC is composed of multiple protein subunits and the relative orientation of these 
subunits within the complex is depicted here.  Apc1p (light blue) is a large scaffolding 
protein that bridges two sub-complexes: the TPR protein containing sub-complex (shades 
of red) and the substrate/E2 interacting sub-complex (shades of green).  The activator 
protein (Cdc20/Cdh1; blue) interacts with the substrate protein (pink) through its degron 
motif and with the APC core through interactions with both Cdc27p and Apc2p.  Apc11p 
associates with the E2 ubiquitin conjugating enzyme (Ubc).  Doc1p interacts with the 
substrate protein and is necessary for the efficient transfer of ubiquitin (Ub) from the E2 
onto the lysine residue(s) of the substrate protein or previously conjugated ubiquitin 
moieties. 
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shown that Apc9p is required for Apc3/Cdc27p association [158,159] and Apc13/Swm1p 
stabilizes the association of Apc3/Cdc27p, Apc6/Cdc16p, Apc9, and Cdc26 with the 
other complex subunits [160], suggesting that Apc9p and Swm1p associate with the TPR 
sub-complex, with Apc9p interacting with Cdc27p and Swm1p reinforcing the entire sub- 
complex.  Mnd2p interacts with protein subunits Apc1, Apc5 and Apc8/Cdc23 in vitro 
[161].  Mnd2p inhibits premature activation of the APC in meiosis and mitosis, by 
interfering with the Ama1p meiotic activator [162,163]. 
 
Structure of the APC 
The crystal structure of several protein subunits of the APC has been determined.  
The Apc10/Doc1 protein structure is composed of a Doc homology domain that forms a 
β-sandwich structure [164].  Mutations within this region perturb APC-activity on those 
substrates containing D-boxes (one of several sequences found in target proteins, see 
below), suggesting the Doc domain is important for substrate recognition [165].  The 
structure of an Apc6/Cdc16-Cdc26 complex showed that Apc6/Cdc16p forms a homo-
dimer via its TPR motifs made from anti-parallel α-helices.  Apc6/Cdc16p also interacts 
directly with Cdc26p to form a hetero-tetramer, generated through the interaction of their 
respective TPR motifs [166].  The crystal structure of the N-terminus of Apc3/Cdc27p 
revealed that, like Apc6/Cdc16p, this protein is able to form a homo-dimer via direct 
interactions between the TPR motifs.  The C-terminal portion of Apc3/Cdc27p is also 
predicted to adopt an overall fold similar to that of Cdc16p [167].  These studies support 
findings that the TPR-containing subunits are present in multiple copies per complex 
[168-170].      
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The overall structure of the intact APC has been determined for S. cerevisiae, S. 
pombe, X. laevis, and humans using cryo-electron-microscopy (EM) [168-172].  The 
specific details of the structures differ amongst species, but the overall shape is triangular, 
with a cavity at the core.  Though the cryo-EM structure revealed the overall shape of the 
enzyme, a more detailed analysis was used to determine the location of subunits within 
the intact complex.  Using antibody labeling, nano-gold labeling, and/or subunit deletions, 
the location of some subunits within the complex has been determined [168-172].  In S. 
cerevisiae, these studies are in good agreement with the work from the Toczyski 
laboratory, discussed above [157].  For example, the catalytic core of the complex (Apc2 
and Apc11) lies in close proximity to Apc1 within the intact structure, while the TPR-
containing subunits (Apc6/Cdc16, Apc8/Cdc23, and Apc3/Cdc27) are present in multiple 
copies and are located peripherally in the complex (Figure 6) [170,171].  
 
Substrate recognition and the role of co-activators 
 The APC utilizes two proteins, cell division cycle 20 (Cdc20p) and Cdc20-
homolog 1 (Cdh1p), to activate the APC core complex.  Without these activators, the 
APC is unable to bind most substrates.  Therefore, the role of Cdc20p and Cdh1p is 
proposed to be substrate-recognition and recruitment to the APC core.  The combination 
of purified APC complexes with in vitro transcribed/translated (IVT) activators results in 
a shift in size on native gels, indicating that a larger complex has been formed.  
Furthermore, addition of IVT-produced substrate results in a super-shift, indicating 
formation of a ternary complex [173].   
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APC-dependent degradation depends upon specific degradation motifs.  The best 
characterized are the destruction box (D-box) and the KEN box motifs.  The D-box was 
first identified in 1991 by Dr. Marc Kirschner’s laboratory and has a consensus sequence 
of RxxLxxxxN (Arg-any two amino acids-Leu-any four amino acids-Asn) [174,175].  
The ‘R’ and ‘L’ of this sequence are invariant amongst substrates, but the ‘N’ is much 
less conserved [176].  The KEN box motif was likewise discovered in Dr. Kirschner’s lab 
[177].  Consistent with the hypothesis that co-activators bind to substrates, the ternary 
complex obtained from incubation of purified APC with IVT-produced activator and 
substrate depends upon an intact D-box or KEN box degron signal [159].  Furthermore, 
several substrates and degron-containing peptides have been shown to directly associate 
with the activator proteins [178-182].  These studies all suggest that the role of the 
activator is to physically associate with the substrate.   
Several studies have also suggested that substrate recognition can be facilitated 
through direct association of the substrate with the APC core.  These results involve the 
Apc10/Doc1p subunit.  Mutation of APC9/DOC1 reduces substrate binding and reaction 
processivity (the ability to add ubiquitin moieties) in a D-box dependent manner, but 
these mutations do not affect activator binding [165,183,184].  These results suggest that 
the substrate may contact both the activator and the APC core through the Apc10/Doc1p 
subunit.  To explore this model of this multi-contact model for substrate binding, two 
groups independently determined the structure of the intact APC in complex with the 
activator subunit and substrate.   
Dr. Jan-Michael Peters’ laboratory used cryo-negative EM to determine the 
structure of an intact S. cerevisiae APC core bound to both Cdh1p and a fragment (~200 
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aa) of Hsl1p that contains the D-box and KEN-box degrons necessary for APC 
recognition [171].  To confirm the specificity of observed interactions, the authors also 
performed these analyses with a fragment containing mutated degrons and in the absence 
of Cdh1p.  The authors found the binding of the Hsl1p fragment to the APC only 
occurred when the D-box was intact and that this interaction was greatly enhanced by the 
presence of Cdh1p.  Furthermore, this fragment underwent ubiquitination, indicating this 
is a functional substrate.  Comparison of the structures obtained both with and without 
substrate revealed a substrate-dependent density located between Cdh1p and 
Apc10/Doc1p, consistent with the role of both the activator and the Apc10/Doc1p subunit 
in substrate binding.   
A similar technique was used by Dr. David Barford’s laboratory to determine the 
substrate-binding sites [185].  The authors used cryo-EM and determined the structure of 
the APC in complex with S. cerevisiae Cdh1p and the same Hsl1p fragment used above.  
The results were similar: Cdh1p and Apc10/Doc1p are bridged by density that is 
dependent on addition of the substrate.  However, these authors went further in their 
exploration into substrate-interactions by determining precisely how the degron motifs 
contributed to these changes.  They repeated the cryo-EM using very short D-box 
peptides, ~18 nt in length, to serve as their ‘substrate’.  This peptide bound and generated 
very similar structural changes to the Hsl1p fragment, but the bridging between 
Apc10/Doc1p and Cdh1p was reduced, confirming that this density arises from the 
substrate peptide.  As seen above, this binding was also eliminated upon mutation of the 
D-box within this peptide.  Surprisingly, however, a KEN-box peptide does not bridge 
Apc10/Doc1p and Cdh1p, arguing that this is a D-box specific interaction.  The authors 
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also showed by NMR that Apc10/Doc1p makes direct contact with the D-box but not 
KEN-box peptides.  These two studies support the model in which the substrate makes 
multiple contacts within the APC, with the activator protein and the core subunit 
Apc10/Doc1p.  The latter study further suggests that this model may specifically apply to 
D-box containing substrates. 
 
Regulation of activity through the cell cycle by phosphorylation  
 APC activity is regulated through the cell cycle.  The complex is active during 
mitosis through G1 phase.  The phosphorylation state of both the APC core subunits and 
co-activators is the major mechanism of regulation.  During mitosis, CDK activity is 
high, resulting in the phosphorylation of core subunits Apc6/Cdc16, Apc8/Cdc23, 
Apc3/Cdc27, and Apc1 [186-188].  Phosphorylation of the complex stimulates the 
association of Cdc20p, thus activating the ligase.  However, at the same time, 
phosphorylation of Cdh1p prevents its association with the complex.  This antagonistic 
phosphorylation stipulates the order in which the APC is activated: APCCdc20p in mitosis 
and APCCdh1p in G1 phase.  The phosphatase that relieves Cdh1p phosphorylation, 
Cdc14p, is sequestered in the nucleolus for the majority of the cell cycle.  Cdc14p is 
released upon signals from the FEAR (Cdc-fourteen early anaphase release) network or 
MEN (mitotic exit network) during anaphase, after chromosome separation (reviewed in 
[189]).  MEN mutants arrest in mitosis with high CDK levels (such as cdc15-2), while 
mutants of the FEAR network delay mitotic exit but do not arrest, indicating that this 
pathway is not essential.   
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Direct phosphorylation of substrates can also regulate APC activity.  Cdc6 
degradation is inhibited by phosphorylation events near the D-box motif [190].  Likewise, 
securin is phosphorylated near its KEN and D-box motifs, preventing efficient APC-
mediated ubiquitination; Cdc14p can release this inhibition [191].  Therefore, there are 
several levels of phosphorylation-mediated regulation on APC activity that ensure the 
precise timing of substrate degradation and cell cycle progression. 
  
Significance of this Study 
 The human telomerase RNA (hTR) was cloned in 1995 and introduction of an 
inhibitory anti-sense hTR into HeLa cells resulted in telomere attrition and eventual cell 
death [44].  While this result indicated a correlation between telomere shortening and loss 
of cell proliferation in human cells, it was in 1998 that a causal relationship was 
demonstrated.  In this pivotal work, the authors introduced the recently cloned catalytic 
subunit [35,36,192], human telomerase reverse transcriptase (hTERT), into normal 
telomerase-negative cells.  These cells exhibited restored telomerase activity, elongated 
telomeres, normal proliferation rates, and increased lifespan [193].  The identification of 
telomerase activity in humans demonstrated the evolutionary conservation of this enzyme 
complex and highlighted its importance in cell proliferation and lifespan, making its 
study relevant to human disease. 
Elucidating the mechanisms that regulate telomerase activity is important because 
of telomerase’s role in both aging and cancer.  Dyskeratosis congenita is a human disease 
that results from mutation of several genes that affect telomerase activity, most strikingly 
the telomerase RNA template, hTR, a homolog to TLC1 RNA.  This mutation results in 
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haploinsufficiency, a situation in which the presence of one copy of the template is not 
enough to maintain proper telomere length and chromosome stability.  Therefore, 
individuals with this disease experience stem cell failure and are at greater risk for 
developing cancer [194].   
 Telomerase is active in germ cells but not in most somatic cells.  Cells that do not 
express telomerase experience telomere shortening each replication cycle. This 
phenomenon has been implicated as a way for a cell to count the number of times it has 
divided.  Therefore, telomeres may act as a tumor-suppression mechanism by limiting the 
number of replication cycles.  However, telomerase is re-activated in about 90% of all 
human cancers (reviewed in [195]).  Therefore, the understanding of telomerase 
regulation could benefit researchers in the development of cancer therapies to inhibit 
telomerase function.   
My published work [196] presented in this dissertation (Chapter II and III) 
focuses on the regulated assembly of the telomerase complex through the temporal 
degradation of the recruitment subunit, Est1p.  Since the fundamental aspects of 
telomeres and telomerase are evolutionarily conserved between S. cerevisiae and humans, 
and assembly is critical to telomerase activity, insight into how the human enzyme is 
regulated can be obtained using this model system.  
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1CHAPTER II 
 
THE ANAPHASE PROMOTING COMPLEX CONTRIBUTES TO THE 
DEGRADATION OF THE S. CEREVISIAE TELOMERASE RECRUITMENT 
SUBUNIT EST1 
 
Introduction 
Telomeres are unique protein-DNA complexes found at the termini of linear 
eukaryotic chromosomes.  These regions are critical for protecting chromosomes against 
nucleolytic digestion and for distinguishing normal chromosome ends from internal 
double-strand breaks.  Loss of telomere function causes end-to-end fusions that result in 
anaphase bridge-breakage cycles and catastrophic genomic instability [195].  While the 
majority of the telomere is comprised of tandem G/T-rich double-stranded DNA repeats, 
the terminus exists as a short 3’-overhang throughout the cell cycle [110,111].  After 
passage of the replication fork in late S phase, the 3’-overhangs are transiently increased 
in length, at least in part due to exonucleolytic digestion of the 5’-strand [17,110-112].  
Telomerase, a ribonucleoprotein complex, can extend these 3’-overhangs by reverse 
transcription, while the conventional lagging-strand DNA replication machinery is 
thought to fill in the 5’-gap [197].   
 
 
________________________________________________________________________ 
1 The work presented in this chapter is published in [196]: Ferguson JL, Chao WCH, Lee 
E, Friedman KL (2013) The Anaphase Promoting Complex Contributes to the 
Degradation of the S. cerevisiae Telomerase Recruitment Subunit Est1p. PLoS ONE 8(1): 
e55055. doi:10.1371/journal.pone.0055055  
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S. cerevisiae telomerase contains three dedicated protein subunits (Est1, Est2 and 
Est3) [33,38,198] and an intrinsic RNA (TLC1) containing the template for nucleotide 
addition [41].  The 1.2 kb TLC1 RNA acts as a scaffold, providing separate binding sites 
for telomerase subunits Est1p and Est2p, the Sm protein complex, and the Ku 
heterodimer [47].  Association of the 7-member Sm complex is critical for RNA 
maturation [46], while Ku binding is important for nuclear retention of the RNA and 
efficient telomerase recruitment to telomeres [53-55].  Est2p, a reverse transcriptase [32], 
and TLC1 RNA are sufficient for in vitro activity and are thus considered the catalytic 
core of the enzyme [199].  Both Est1p and Est3p are regulatory or accessory proteins 
since each is dispensable in vitro but required in vivo to maintain telomere length 
[33,38,198,199].  The Est3p regulatory subunit is recruited to the complex through direct 
interactions with Est1p and Est2p, and stimulates telomerase activity in vitro [63,81]. 
Est1p binds TLC1 RNA via three secondary structural elements within sub-helix 
IVc: a pentanucleotide bulge, an adjacent internal loop, and a single-stranded region at 
the base of the sub-helix [51,52].  In addition to its interaction with the RNA, Est1p is 
also important for the recruitment of telomerase to the telomere through a direct 
interaction with the telomeric single-stranded DNA binding protein, Cdc13p [96-100].  
The Est1 protein undergoes proteasome-dependent cell cycle-regulated destruction in G1 
phase, thereby preventing telomerase complex assembly during G1 phase when 
telomerase is not active at telomeres [101].   
Protein destruction by the proteasome is regulated through the attachment of the 
small polypeptide ubiquitin to target molecules.  Such ubiquitin-dependent protein 
degradation is accomplished through a multi-step process: the ubiquitin moiety is 
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activated by an E1 activating enzyme, transferred to an E2 conjugating enzyme, and 
finally, covalently attached to lysine residues present within a target protein that is bound 
to an E3-ligase.  Multiple rounds of this process result in polyubiquitinated proteins that 
are subsequently delivered to the 26S proteasome for degradation.  Temporal 
coordination of ubiquitination and proteolysis of key regulatory proteins is critical for 
unidirectional progression of the cell cycle [200].  One of the well-studied poly-
ubiquitinating E3 complexes with this role is the Anaphase Promoting Complex (APC).   
The APC is a multi-subunit E3 ubiquitin ligase that is critical for transit through 
the cell cycle.  Although the core subunits are constitutively expressed [161,201,202], 
APC functionality oscillates, exhibiting no activity in S and G2 phase, and high activity 
during mitosis and G1 phase [203].  The APC utilizes two evolutionarily conserved, 
WD40-domain containing activators, Cdc20p/Fizzy and Cdh1p/Hct1/Fizzy-related [204-
206].  These activators bind directly to substrates via degradation motifs 
[173,178,181,182], the best characterized being the Destruction box (D-box: an arginine 
and leucine separated by any two amino acids, RxxL) and KEN-box [174,177,207].  The 
binding of these activators to the APC core particle is tightly regulated: Cdc20p 
associates when cyclin-dependent kinase (CDK/Cdc28p) activity is high in mitosis, while 
Cdh1p association is inhibited by phosphorylation and therefore occurs when CDK 
activity is low at the end of mitosis through G1 phase [208-210].  The direct binding of 
pseudosubstrate inhibitors and degradation of activator proteins also contribute to 
temporal regulation of APC activity [176].  APCCdc20p is critical during mitosis when 
specific recognition and subsequent destruction of the separase inhibitor (securin/Pds1p) 
results in cohesin cleavage, and thus sister-chromatid separation [206,211].  APCCdh1p 
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activity promotes exit from mitosis and ensures that CDK levels remain low, allowing for 
loading of replication origins with initiation proteins prior to the beginning of S phase, 
when CDK activity increases [176,212,213]. 
Est1p undergoes cell cycle-regulated degradation during G1 phase, thereby 
preventing Est3p recruitment and telomerase complex assembly [101].  Here I present 
evidence that Est1 protein levels oscillate during the cell cycle through an APC-
dependent mechanism in vivo.  Degradation requires three sequences in Est1p that match 
the D-box consensus, consistent with direct recognition of Est1p by the APC.  However, 
recombinant Est1 protein is not degraded or ubiquitinated by the APC in vitro, suggesting 
that Est1p either lacks the necessary structure or modification(s) that influence APC 
recognition in vivo or is an indirect target of the APC.  Because Est1p stimulates 
association of Est3p with the telomerase complex, these results shed light on the 
regulation of yeast telomerase biogenesis and demonstrate an additional connection 
between telomere maintenance and cell cycle regulation pathways.  
  
Results and Discussion 
 
Est1p is stabilized in early S phase 
The telomerase recruitment protein, Est1p, undergoes degradation in G1 phase but 
not G2/M phase [101].  To more thoroughly examine the temporal regulation of Est1 
protein levels, cells expressing MYC13-tagged EST1 from its endogenous locus were 
arrested at three points in the cell cycle: G1 with the mating pheromone, alpha-factor; 
early S with the ribonucleotide reductase inhibitor, hydroxyurea; and late G2/M with the  
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Figure 7.  Flow cytometry of arrested cells. 
Example of the typical flow cytometry histograms resulting from S. cerevisiae strains 
used in this study left untreated (asynchronous; Asyn.) or arrested as indicated.  The 
profile of hydroxyurea-blocked cells is nearly indistinguishable from that observed upon 
treatment with α-factor, consistent with an early S phase arrest in the vast majority of 
cells. 
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microtubule destabilizing agent, nocodazole.  The efficiency of arrest was confirmed to 
be greater than 95% in each experiment by flow cytometry (Figure 7) and observation of 
bud index (data not shown).  As expected, Est1-MYC13p was readily detected in whole-
cell extract from asynchronously growing cells but not in the untagged control strain, 
indicating specificity of the MYC-antibody (Figure 8A, lanes 1 and 2).  In agreement 
with previous observations [100,101], endogenously expressed Est1-MYC13p was 
undetectable in G1 phase and abundant in G2/M-arrested cells (Figure 8A, compare lanes 
3 and 5).  Similar to G2/M-arrested cells, Est1-MYC13p was readily detected from early 
S-arrested cells (Figure 8A, lane 4), suggesting that Est1 protein levels increase as cells 
enter S phase.   
 Although EST1 transcript levels are ~3 fold lower in G1 phase than during G2/M 
[214,215], we have previously shown that differential protein stability is an important 
factor determining Est1p levels during the cell cycle [101].  To examine the kinetics of 
Est1p degradation at different points in the cell cycle, protein half-life was determined 
using a standard promoter shut-off assay.  Following a brief induction of HA3-EST1 
expression from the GAL1-promoter, both transcription and translation were inhibited 
and protein abundance was examined over time.  As shown in Figure 8B, and in 
agreement with published work [101], HA3-Est1p was rapidly degraded during a G1 
phase arrest, but was more stable during a G2/M phase arrest [101].  In accordance with 
the steady state protein levels (Figure 8A), overexpressed HA3-Est1p was also stable 
when cells were arrested in early S phase with hydroxyurea (Figure 8B, middle).  
Quantification of these assays confirmed a statistically significant increase in protein 
half-life during early S and G2/M phase as compared to G1 phase (Figure 8C;   
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Figure 8.  Est1p is unstable in G1 phase, but stable in early S and G2/M phases. 
(A) Endogenously expressed Est1p-MYC13p levels during cell cycle arrests.  Strains 
YKF800 (untagged; lane 1) and YKF801 (EST1-MYC13; lanes 2-5) were grown 
asynchronously at 30°C to mid-log phase and then left untreated (asynchronous) or 
arrested by addition of α-factor, hydroxyurea, or nocodazole, as indicated.  When 95% of 
the population was arrested, as monitored by the bud-index, cells were harvested.  
Whole-cell extract was prepared and western blotted using anti-MYC, anti-Clb2p, and 
anti-Actin antibodies, as indicated.   
(B) Half-life of HA3-Est1p during cell cycle arrests.  Strain YKF802 containing plasmid 
pVL242RtoA (PGAL1-HA3-EST1) was grown asynchronously at 30°C to mid-log phase 
and arrested with α-factor, hydroxyurea, or nocodazole, as indicated.  When 95% of the 
population was arrested, as monitored by the bud-index, expression of HA3-EST1 was 
induced with addition of galactose and then subsequently repressed (after 1 hour) with 
glucose and cycloheximide (time 0).  Samples from cells harvested at the indicated times 
were western blotted with anti-HA, anti-Clb2p and anti-Actin antibodies, as indicated.  
An induced asynchronous sample of strain YKF806 + pVL242RtoA (clb2Δ; left panel), 
served as a negative control for Clb2p and positive control for HA3-Est1p detection.  An 
uninduced asynchronous sample of strain YKF802 + pVL242RtoA (Raff; left panel) 
served as a positive control for Clb2p detection and negative control for HA3-Est1p 
specificity.  A non-specific background band is indicated by .   
(C) Quantification of data shown in (B), as described in Materials and Methods.  The 
calculated half-lives were averaged from independent biological replicates: αF (α-factor), 
n=7; HU (hydroxyurea), n=4; NOC (nocodazole), n=4.  Error bars are standard deviation 
from the mean.  Both HU and NOC are statistically different from αF by two-tailed t-test 
(p-values 1.1 x10-5 and 1.1 x10-6, respectively) as denoted by *. 
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p-values =1.1x10-5 and 1.1x10-6, respectively).  Together, these results suggest that Est1p 
is rapidly degraded during G1 phase, stabilizes in early S phase, and remains stable 
through G2/M phase. 
 
Est1p is more stable in G1 phase when APC activity is compromised 
The pattern of Est1p degradation during the cell cycle is reminiscent of that 
observed for targets of the E3-ubiquitin ligase complex, APC.  As a comparison, levels of 
the B-type cyclin Clb2p, a known APC substrate [216,217], were monitored within the 
same extracts utilized for Est1p detection.  As expected, Clb2p was undetectable in G1 
and robustly detected in both S and G2/M arrested cells (Figure 8A and 8B).  In addition 
to confirming the efficiency of cell cycle arrest, these results led me to hypothesize that 
Est1p degradation depends upon APC function. 
I monitored the degradation rate of overexpressed HA3-Est1p in alpha-factor 
arrested cells expressing the temperature-sensitive (ts) allele cdc16-123.  This allele 
renders the APC non-functional at the restrictive temperature of 37°C and exhibits 
proteolysis defects with known APC substrates [216,217].  A strain harboring the cdc16-
123 allele was transformed with a complementing CEN vector expressing wild-type 
CDC16 under control of its endogenous promoter (denoted CDC16) or an empty-vector 
(denoted cdc16-123).  Using the promoter shut-off assay described above, the average 
half-life of overexpressed HA3-Est1p was greater in the cdc16-123 strain than in the 
complemented strain (Figure 9A and 9C) and trended toward significance with a p-value 
of 0.08.  Therefore, I wanted to verify the relevance of this trend by examining other 
strains that compromise APC function in vivo.  
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Figure 9.  APC function is required for normal Est1p degradation during G1 phase.   
(A) HA3-Est1p stability increases when APC function is compromised.  Western blots of 
Est1p stability assays from strain K4438 (cdc16-123) harboring pKF600 (GAL1-HA3-
EST1) plus either a complementing vector pRS416-CDC16 (labeled “CDC16”) or an 
empty vector pRS416 (labeled “cdc16-123”) were conducted as described in Materials 
and Methods.  An uninduced sample (Raff) served as a negative control for HA3-Est1p 
specificity.   
(B) HA3-Est1p is stabilized in APC deletion mutants.  Western blots of Est1p stability 
assays from strains YKF802 (Wild Type), YKF803 (apc9Δ), YKF804 (mnd2Δ), YKF805 
(swm1Δ), YKF806 (clb2Δ) and YKF807 (clb2Δcdh1Δ) containing pVL242RtoA (PGAL1-
HA3-EST1) were conducted as described in Materials and Methods.  For YKF805 
(swm1Δ), an uninduced asynchronous sample (Raff) served as a positive control for 
Clb2p detection and negative control for HA3-Est1p specificity, while an uninduced 
asynchronous sample of strain YKF806 (clb2Δ) served as a negative control for Clb2p 
detection.   
(C) Quantification of results shown in (A).  Bars represent the average HA3-Est1p half-
life from three independent biological replicates.  Error bars are standard deviation of the 
mean (p-value = 0.08 by two-tailed t test).   
(D) Quantification of results shown in (B).  Bars represent the average HA3-Est1p half-
life from independent biological replicates: n=3 for all strains except clb2Δcdh1Δ, where 
n=4.  Error bars are standard deviation from the mean.  By two-tailed paired t-test, there 
is a significant difference between the control (WT) and swm1Δ (p-value 0.0002) but not 
between WT and apc9Δ (p-value 0.49) or mnd2Δ (p-value 0.83).  There is a significant 
difference between the control (clb2Δ) and clb2Δcdh1Δ strains (p-value 0.003).  
Significant differences are denoted by *. 
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Although APC activity is critical for cell viability, several subunits of this large 
E3 ubiquitin ligase are encoded by non-essential genes (e.g. Apc9p, Mnd2p, and 
Swm1p).  Proteolysis of known APC substrates is minimally compromised in apc9Δ and 
mnd2Δ cells, suggesting that these two subunits exhibit substrate-specific effects or have 
minor contributions to full APC function.  However, proteolysis of known APC 
substrates securin/Pds1p, Clb2p, Cdc5p, and Ase1p is decreased in swm1Δ cells, 
indicating a greater contribution to full APC activity [160,218].  Using the promoter shut-
off assay, the half-life of overexpressed HA3-Est1p was determined in apc9Δ, mnd2Δ, or 
swm1Δ cells arrested in G1 phase with alpha-factor (Figure 9B and 9D).  HA3-Est1p was 
significantly more stable during G1 phase in swm1Δ cells than in wild-type cells (p-value 
= 0.0002), while the rate of degradation was unaffected by the deletion of either apc9 or 
mnd2 (p-values = 0.49 and 0.84, respectively).  Endogenously expressed Clb2p was 
detected in the same swm1Δ samples, but was undetectable from apc9Δ or mnd2Δ 
samples (Figure 9B and data not shown), confirming the predicted phenotype of these 
strains.  Thus, like known APC targets, normal Est1p degradation during G1 phase 
requires Swm1p function. 
During G1 phase, the APC is associated with the activator protein Cdh1p.  Like 
SWM1, CDH1 is non-essential, most likely because securin and B-type cyclins, essential 
substrates of the APC, are sufficiently targeted by the mitotic activating factor, Cdc20p 
[156].  I examined the protein half-life of Est1p in cdh1Δ cells arrested in alpha-factor.  
Since deletion of cdh1 results in cyclin accumulation that leads to bypass of the alpha-
factor arrest [205,212,219], these analyses were performed in a clb2Δ background to 
prevent cells from moving into S phase.  Consistent with the results obtained in swm1Δ   
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cells, overexpressed HA3-Est1p was significantly stabilized in clb2Δcdh1Δ cells arrested 
in G1 phase (p-value = 0.003; Figure 9B and 9D, compare to clb2Δ).  While clearly 
increased in comparison to the wild-type strain, the half-life of Est1p in alpha-factor 
arrested swm1Δ (T1/2 = 23 +/- 2.5 mins) or clb2Δcdh1Δ (T1/2 = 25 +/- 4.3 mins) strains 
was lower than that of the corresponding WT strain arrested with hydroxyurea (T1/2 = 33 
+/- 5.8 mins; p-values 0.04 and 0.06, respectively) or nocodazole (T1/2 = 33 +/- 3.7 mins; 
p-values 0.01 and 0.03, respectively).  These differences are consistent with the retention 
of partial APC activity in these viable strains.  Collectively, these experiments support 
the hypothesis that the APC plays a role in the G1-specific degradation of Est1p. 
 
CDH1 is required for the cell-cycle oscillation of Est1 protein levels 
 The loss of Est1p during an alpha-factor arrest (Figure 8A) could be over-
emphasized due to the artificial length of G1 phase.  To confirm the kinetics with which 
Est1p levels fluctuate as cells enter and traverse an unperturbed G1 phase, I examined 
levels of endogenously expressed Est1-MYC13p after release of cdc15-2 cells from 
mitotic arrest.  CDC15 encodes a protein kinase required for mitotic exit and incubation 
of cdc15-2 cells at the restrictive temperature of 37°C results in cell cycle arrest in late 
anaphase/telophase [220].  Because CDK activity is elevated and the Cdc14p phosphatase 
is sequestered in the nucleolus and unable to dephosphorylate Cdh1p [189,208-210], 
APCCdh1p is not active during the cdc15-2 arrest.  In contrast, the observation that cdc15-2 
arrested cells have separated chromosomes indicates that APCCdc20p is active and able to 
mediate Pds1p proteolysis prior to the arrest point.  cdc15-2 cells were incubated at the 
restrictive temperature until 95% of the population was arrested with the characteristic 
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“dumbbell” morphology and then released from the arrest by shifting back to the 
permissive temperature of 23°C.  Samples were harvested every 20 mins following 
release.  Synchrony of the release was monitored by analysis of Clb2p levels, observation 
of the bud index (Figure 10), and flow cytometry (data not shown). 
In agreement with published reports, endogenous Clb2p levels decreased upon 
release from the cdc15-2 arrest [205,221,222], with the lowest point of expression at 40 
to 60 mins Figure 11A).  Approximately 50% of cells show the first evidence of bud 
formation 60 mins after release (Figure 10), consistent with the interpretation that the 
trough of Clb2 expression corresponds to G1 phase.  Examination of Est1-MYC13p levels 
within these same samples revealed a similar pattern; the lowest point of expression 
occurred 40-60 mins after release from the cdc15-2 block (Figure 11A).  Four 
independent biological replicates were done to demonstrate the reproducibility of this G1 
phase decrease for both Clb2p and Est1-MYC13p (Figure 11A). The expression of both 
proteins at 40 and 60 mins after release was significantly decreased from the protein 
levels observed at the cdc15-2 arrest (p-values for Clb2p: 6.0x10-5 and 1.7x10-4, 
respectively; p-values for Est1-MYC13p: 3.7x10-4 and 1.9x10-4, respectively). 
Although the pattern with which Clb2p and Est1p declined in abundance after 
cdc15-2 release was very similar, only Clb2p showed a large increase in expression at the 
end of the time course (100 mins) compared to the starting protein level.  I attribute this 
behavior to the previous observation that a fraction of Clb2p undergoes APCCdc20p-
dependent degradation [222], which would be expected to have occurred prior to the 
cdc15-2 arrest.  Therefore, the starting protein levels observed for Clb2p at the cdc15-2 
arrest may already be partially reduced, with additional degradation attributable to  
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Figure 10.  Cells released from the cdc15-2 arrest proceed synchronously into the 
next cell cycle.  
Budding index of cells collected at the indicated times after release from the cdc15-2 
arrest (Figure 11).  Results are from a single WT (light) and cdh1Δ (dark) assay and 
indicate the percentage of cells with visible buds.  This result is representative of the 
pattern observed from the cdc15-2 arrest and release assays. 
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Figure 11.  Cell-cycle oscillation of Est1p requires Cdh1p.  
(A) Est1 protein levels oscillate through the cell cycle.  Strain YKF808 (cdc15-2 EST1-
MYC13) was grown asynchronously at 23°C to mid-log phase and shifted to the restrictive 
temperature (37°C) for 3.5 hrs.  When 95% of the cells were arrested, as monitored by 
bud-index (Figure 10), the culture was returned to the permissive temperature (23°C; 
time 0).  Whole-cell extract was prepared from samples harvested every 20 mins 
following release and western blotted using anti-MYC, anti-Clb2p, and anti-Actin 
antibodies, as indicated.  YCM191 (cdc15-2) served as the untagged (No MYC) control 
for Est1-MYC13p and was harvested following the 37°C incubation period.  Est1-
MYC13p and Clb2p intensity at each time were normalized to input (actin) and starting 
amount (time 0).  Bars represent the average of four independent biological replicates for 
Est1-MYC13p (light) and Clb2p (dark); error bars are standard deviation of the mean.   
(B) Deletion of CDH1 perturbs the oscillation of Est1-MYC13p through the cell cycle.  
Strain YKF809 (cdc15-2 cdh1Δ EST1-MYC13) was treated as in (A), except the bars 
represent the average of three independent biological replicates.  
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APCCdh1p activity.  The failure of Est1p to accumulate above the starting amount by the 
end of the time course suggests that Est1p may not undergo degradation in late mitosis, 
prior to the cdc15-2 arrest point.  
Since Cdh1p plays a role in Est1p degradation during G1 phase (Figure 9B and 
9D), I hypothesized that deletion of this APC-activator would abrogate the protein 
oscillation pattern observed from cells released from a cdc15-2 arrest.  A cdh1Δ cdc15-2 
strain was incubated at restrictive temperature until >95% of the cells were arrested and 
then released by lowering the temperature.  As monitored by both the bud index (Figure 
10) and flow cytometry (data not shown), the cells proceeded into the next cell cycle 
similarly to wild type, with the emergence of small buds beginning at 60 mins after 
release.  Consistent with published work, Clb2p levels no longer decreased during transit 
through G1 phase in cdh1Δ cells (Figure 11B; [205]).  Importantly, Est1-MYC13p also 
did not exhibit a decline in protein levels as cells proceeded through G1 phase following 
release from the cdc15-2 arrest (compare Figure 11A and 11B).  Based on the preceding 
analysis of protein levels as cells exit mitosis and enter the following S phase, I conclude 
that Est1p likely undergoes proteolysis solely during G1 phase, stabilizes as cells transit 
through S phase, and remains stable through mitosis.  Furthermore, APCCdh1p is the 
primary regulator of the G1 phase-specific proteolysis of Est1p.  
As the cdh1Δ cdc15-2 cells proceeded through the later timepoints of the release, 
the protein levels of both Est1-MYC13p and Clb2p increased over their respective starting 
amounts (time 0).  This has been reported for Clb2p [205,222] and may result from the 
combination of lack of degradation and additional transcription/translation as cells exit 
the arrest [101,214,215,223,224].  As mentioned above, APCCdc20p also degrades a pool 
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of Clb2p during mitosis [222], prior to the cdc15-2 arrest point, leading to a partially 
reduced starting amount.  However, since this experiment depends upon a dramatic 
temperature shift (23° to 37°), I also cannot eliminate artifacts resulting simply from the 
temperature change.  Though the temperature is slowly raised to prevent heat-shock 
effects  [225], it remains possible that the high temperature causes a drop in the transcript 
level that then recovers following release at permissive temperature.  If a Northern Blot 
of transcript levels confirms this hypothesis, a simple modification of the experiment 
could eliminate these concerns: a nocodazole block and release of wild-type yeast.  
Furthermore, the experiment could be done by arresting at the restrictive temperature for 
cdc15-2 and then inducing expression of wild-type CDC15 using an inducible promoter, 
eliminating the need for a return to the permissive temperature to release the arrested 
cells into a synchronous cell cycle.  
   
Mutation of cis-acting sequences stabilizes Est1p in G1 phase 
 The data presented thus far demonstrate that the APC influences the G1 phase-
specific degradation of Est1p.  However, these experiments do not address whether Est1p 
is a direct substrate of the APC.  Substrates of the APC are recognized through specific 
degron motifs such as the Destruction box (D-box: sequence RxxL) and KEN box 
[174,177,207].  If Est1p is a direct target of APCCdh1p, I would predict EST1 to encode 
specific degron(s) important for the recognition and subsequent proteolysis of Est1p.  
Examination of the amino acid sequence of Est1p revealed the presence of six putative D-
boxes positioned in pairs throughout the protein (Figure 12A).  To test if any of these 
putative D-boxes has a role in Est1p degradation during G1 phase, I mutated the 
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important arginine (R) and leucine (L) residues of each consensus sequence to alanine 
(A) and determined protein half-life using a promoter shut-off assay in cells arrested with 
alpha-factor.  Individual mutation of putative D-boxes 1, 2, and 4 stabilized the protein 
during G1 phase while no significant increase in half-life was observed upon mutation of 
putative D-boxes 3, 5, or 6 (Figure 12B and Figure 13A; data not shown).  Because the 
degron motifs occurred in pairs, I also asked whether mutating each pair of putative D-
boxes (1+2, 3+4, or 5+6) would further inhibit proteolysis.  Consistent with the single D-
box data, combined mutation of 1+2 or 3+4 resulted in stabilization of the protein, but the 
effect was not additive.  No stabilization was observed upon mutation of D boxes 5+6 
(Figure 12B and Figure 13A).  The extent to which the half-life increased for either the 
single or combined mutations was not statistically different from the half-life observed 
during a nocodazole (G2/M phase) arrest, suggesting that the loss of a single D-box motif 
is sufficient to stabilize the protein in G1 phase. 
To corroborate the results obtained with the specific point mutations described 
above, I also monitored the half-life of several deletion variants of Est1p.  Deletion of the 
C-terminal 300 amino acids (denoted CΔ300 in Figure 12A) removes putative D-boxes 5 
and 6, previously shown not to contribute to Est1p degradation during G1 phase (Figure 
12B).  Consistent with that conclusion, the half-life of Est1pCΔ300 remained unchanged 
compared to the full-length protein, suggesting that putative D-boxes 5 and 6 are not 
degron motifs (Figure 12C and Figure 13B).  A larger C-terminal deletion (CΔ500) did 
not express well; I was therefore unable to examine the stability of an Est1p peptide 
containing only D-boxes 1 and 2 (data not shown).  I next generated systematic deletions 
from the N-terminus of EST1 to assess the influence of D-boxes 1 and 2 on Est1p  
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Figure 12. Est1p degradation in G1 phase requires three destruction boxes (D-
boxes). 
(A) Schematic of EST1 shown to scale.  EST1 contains six putative D-boxes with 
sequence RxxL (boxes labeled 1-6).  Deletion of the C-terminal 300 amino acids 
(CΔ300) results in a truncated protein that removes putative D-boxes 5 and 6.  The N-
terminal 52 amino acids are shown, with putative D-boxes 1 and 2 outlined.  Upward 
pointing black triangles represent the position of the indicated N-terminal deletion.   
(B) D-boxes 1, 2, and 4 contribute to Est1p degradation.  YKF802 containing pKF600 
(GAL1-HA3-EST1) plasmids expressing either wild-type EST1 (WT) or the D-box (DB) 
mutated (RxxL to AxxA) est1 alleles indicated were treated as in Figure 8B, except 
strains were arrested with α-factor.  Bars represent the average HA3-Est1p half-life for 
three independent biological replicates; error bars are the standard deviation of the mean.  
Using a two-tailed t-test, there is no significant difference from WT for D-box 3 (p-value 
0.833) or D-boxes 5+6 (p-value 0.104).  D-box 1 (p-value 0.027), D-box 2 (p-value 
0.012), D-boxes 1+2 (p-value 0.001), D-box 4 (p-value 0.001) and D-boxes 3+4 (p-value 
0.002) are significantly different than WT, denoted by *.   
(C) Deletion of D-box 1 or 2 stabilizes Est1p during G1 phase.  YKF802 containing 
pKF600 plasmids expressing either wild-type EST1 (WT) or the est1 deletion variants 
indicated (CΔ300, NΔ7, NΔ15, NΔ25, NΔ35 or NΔ50) were treated as in (A).  Bars 
represent the average HA3-Est1p half-life for independent biological replicates: n=3 for 
each variant except NΔ50, where n=4.  Error bars are standard deviation from the mean; 
significance is denoted by *.  By a two-tailed t-test, there is no significant difference 
between WT and CΔ300 (p-value 0.445) or NΔ7 (p-values 0.188).  The half-lives 
observed for NΔ15 (p-value 0.0003), NΔ25 (p-value 0.008), NΔ35 (p-value 0.005) and 
NΔ50 (p-value 0.02) are significantly different from WT. 
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Figure 13.  Est1p degradation in G1 phase depends upon specific degron motifs. 
(A) Western blots of Est1p stability assays from strain YKF802 containing pKF600 
(GAL1-HA3-EST1) plasmids expressing the D-box (DB) mutated (RxxL to AxxA) est1 
alleles indicated (DB1; DB2; DB1+2; DB3; DB4; DB3+4; DB5+6), treated as in Figure 
8B (α-factor).   
(B) Strain YKF802 containing pKF600 plasmids expressing the deletion variants 
indicated (CΔ300, NΔ7, NΔ15, NΔ25, NΔ35 or NΔ50) were treated as in (A).   
Results are quantified in Figure 12. 
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degradation.  The N-terminal boundaries of D-boxes 1 and 2 are located at amino acid 19 
and 41, respectively (Figure 12A).  I constructed five N-terminal deletions: est1NΔ7, 
est1NΔ15, est1NΔ25, est1NΔ35, and est1NΔ50.  Examination of the protein half-life via 
promoter shut-off assay revealed no stabilization with the smallest deletion (Est1pNΔ7), 
but the half-lives of Est1pNΔ25, Est1pNΔ35, and Est1pNΔ50 were increased (Figure 12C and 
Figure 13B).  Again consistent with the lack of additivity previously observed, loss of 
putative D-box 1 (Est1pNΔ25 and Est1pNΔ35) was equivalent in effect to loss of both 
putative D-boxes 1 and 2 (Est1pNΔ50).  The extent of stabilization observed in the deletion 
variants was similar to that observed with the point mutations (compare Figure 12B and 
12C).  Est1pNΔ15 was more stable than the full-length protein even though no portion of a 
predicted D-box was deleted with this construct (Figure 12C and Figure 13B).  Since this 
deletion retains only 3 amino acids N-terminal to the beginning of D-box 1, I attribute 
this stabilization to misfolding of D-box 1 and disrupted recognition by APCCdh1p.  
However, it is possible that a novel degron motif exists between amino acids 7 and 15.  
These results are consistent with Est1p being a direct substrate of the APC and suggest 
that EST1 encodes three degron motifs (D-boxes 1, 2, and 4) important for recognition 
and subsequent degradation during G1 phase. 
 
Neither proteolysis nor ubiquitination of recombinant Est1p by the APC occurs in 
vitro 
The analyses described above suggest that Est1p undergoes G1-specific 
degradation that is dependent upon direct recognition of degron motifs within the protein 
by APCCdh1p.  To examine the direct effect of APCCdh1p on Est1p, I monitored degradation 
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of recombinant Est1p using Xenopus laevis egg extracts either without (APC inactive) or 
with (APC active) human Cdh1 supplementation.  Recombinant Drosophila cyclin B 
served as a positive control for APC-mediated degradation, while firefly luciferase served 
as the negative control.  As expected, luciferase remained stable while cyclin B was 
efficiently degraded in the presence of Cdh1 (Figure 14A).  However, there was no 
observed degradation of recombinant Est1p when Cdh1 was added (Figure 14A).   
To eliminate the possibility of cross-species incompatibility, I collaborated with 
William Chao, a graduate student in David Barford’s laboratory in London, UK.  Using 
my supplied plasmids, William tested whether Est1p is ubiquitinated by APCCdh1p in vitro 
when all components of the assay are either purified from S. cerevisiae or are 
recombinant proteins of S. cerevisiae origin.  35S-labeled substrates synthesized in rabbit 
reticulocyte lysate (RRL) were incubated with methylated-ubiquitin and recombinant 
Cdh1p in the presence (+) or absence (−) of purified S. cerevisiae APC complexes 
(Figure 14B).  Methylated-ubiquitin prevents poly-ubiquitin chain formation; thus, 
substrate ubiquitination results in two observable changes: 1) loss of signal corresponding 
to the unmodified protein and 2) appearance of a ladder of higher molecular weight bands 
indicative of covalent attachment of a single ubiquitin moiety to individual lysines.  S. 
cerevisiae securin/Pds1p, previously shown to undergo APCCdh1p-dependent 
ubiquitination in vitro [226], served as a positive control.  As expected, Pds1p was 
ubiquitinated in a manner dependent upon addition of both purified APC and 
recombinant Cdh1p [indicated by the ladder of higher molecular weight species and loss 
of the unmodified signal (Figure 14B, lane 2)].  In contrast, Est1p was not detectably 
ubiquitinated in this assay (Figure 14B, compare lanes 3 and 4). 
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Figure 14.  Est1p is not a target of the APC in vitro.  
(A) Est1p is not degraded by the APC in vitro.  X. laevis egg extract (− CDH1) was 
activated by the addition of in vitro transcribed human Cdh1 to obtain APC-activated 
extract (+ CDH1).  35S-labeled substrate proteins (S. cerevisiae Est1p, D. melanogaster 
Cyclin B, or firefly luciferase) were incubated with either inactive (− CDH1) or activated 
extract (+ CDH1) as described in Materials and Methods.  Samples were removed at the 
indicated times, separated by gel-electrophoresis and exposed to a phosphor-imager 
screen.   
(B) Est1p is not ubiquitinated in vitro.  35S-labeled substrates (S. cerevisiae Est1p and 
Pds1p) were incubated with Ubc4p (E2 ligase), recombinant S. cerevisiae Cdh1p, and 
methylated-ubiquitin in the absence (− ; lanes 1 and 3) or presence (+ ; lanes 2 and 4) of 
purified S. cerevisiae APC complexes.  Reactions were separated by gel electrophoresis 
and detected by autoradiography film.  Black arrows indicate the unmodified protein.  
The vertical line indicates the region where ubiquitin-conjugated forms of Pds1p migrate.  
This experiment was performed by William Chao. 
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Experiments designed to detect substrate ubiquitination in vivo are challenging 
because the ubiquitinated forms represent a small fraction of the total protein, are rapidly 
degraded by the proteasome, and are acted on by deubiquitinating enzymes (Dubs).  
Despite using techniques designed to limit these concerns [227,228], I have not detected 
ubiquitination of overexpressed Est1p in vivo (data not shown).  However, these analyses 
have not been exhaustive and do not rule out the possibility that a critical pool of Est1p 
undergoes ubiquitination in vivo.   
The lack of APCCdh1p-dependent ubiquitination or degradation of Est1p in vitro 
using two different assays contrasts with our identification of degradation motifs in Est1p 
that resemble those utilized by APCCdh1p in other substrates and that are required for 
Est1p degradation during G1 phase (Figure 12).  One possibility is that modifications of 
Est1p influence recognition by APCCdh1p in vivo and that these modification(s) are not 
appropriately mimicked upon expression of Est1p in RRL.  Although much of the 
regulation of APC-mediated degradation occurs through direct modulation of APC 
activity, post-translational modification of substrate molecules has been found to affect 
recognition by the APC in several cases including Cdc6, securin, and Aurora A 
[176,190,191,229,230].  While it was recently reported that Est1p is not detectibly 
phosphorylated in vivo [81], the presence of other post-translation modifications has not 
been addressed.  I also cannot exclude the possibility that recombinant Est1p is mis-
folded, precluding recognition by APCCdh1p in the in vitro assays. 
An alternate possibility is that the amino acids required for Est1p degradation in 
vivo (Figure 12) do not mediate direct interaction with APCCdh1p, but are instead required 
for recognition by a currently unidentified ubiquitin ligase or protease.  Because our 
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results provide strong evidence that Est1p degradation depends upon APCCdh1p function 
(Figure 9 and Figure 11), I would need to postulate that the effect of the APC is indirect.  
For example, Est1p may be targeted for degradation via a mechanism that itself is under 
positive regulation by the APC, reminiscent of cohesin cleavage by separase after 
Pds1/securin degradation via APCCdc20p [231].  
Previous work has shown that Est1p regulates the assembly of the telomerase 
complex in vivo.  However, even in the presence of abundant Est1 protein and telomerase 
complex assembly, telomerase is unable to elongate telomeres during G1 phase [101].  
This observation suggests that additional regulatory mechanisms prevent inappropriate 
telomerase activity.  A role for the Rif2 protein in G1-specific telomerase inhibition was 
recently reported [232].  However, these results do not rule out an additional regulatory 
role for Est1p degradation during G1 phase.  In this light, it is intriguing that all of the D-
box stabilizing mutations (Figure 12) cause telomere shortening when expressed under 
control of the endogenous promoter in est1Δ cells (Figure 15).  While this observation 
suggests that the stabilization of Est1p during G1 phase may be deleterious, I cannot rule 
out the possibility that the mutations affect other aspects of Est1p function.   
In summary, our in vivo results are most consistent with a model in which Est1p 
levels oscillate through the cell cycle, undergoing G1-specific degradation that is 
dependent upon APCCdh1p-mediated recognition of specific degron motifs within the 
protein.  Reduced Est1p levels during G1 phase are in turn predicted to restrict the 
assembly of the active telomerase complex [101].  Although I cannot rule out misfolding 
of the recombinant protein as an explanation for the lack of Est1p degradation in vitro, 
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these results raise the intriguing possibility that additional regulatory events modulate 
Est1p abundance in a manner that depends upon APC function. 
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Figure 15.  Stabilized alleles of Est1p fail to complement an est1 deletion.  
Independent isolates from strain YKF810 (est1Δ) harboring plasmids pRS416 (empty 
vector: ev), pRS416-EST1 (EST1), or the est1 alleles indicated (DB1; DB2; DB1+2; 
DB3; DB4; DB3+4) were propagated for >100 generations.  DNA was extracted, 
digested with XhoI, Southern blotted, and probed with a randomly labeled telomeric 
DNA probe.  Yʹ′-elements and telomere fragments from Yʹ′-containing chromosomes are 
indicated.  Positions of molecular weight markers (M) are indicated in kilobases (kb).  
Alleles partially compromised for function have telomere fragments that are shorter than 
the wild-type control while severely compromised alleles result in the formation of 
telomerase-negative survivors characterized by Yʹ′-element amplification and/or 
heterogeneous telomere length (smears throughout the lane).  
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CHAPTER III 
 
THE CONSEQUENCE OF STABILIZED EST1 
 
Introduction 
 Telomeres are the unique protein-DNA regions at the ends of linear eukaryotic 
chromosomes that are critical for protecting chromosomes against deleterious events such 
as nucleolytic digestion and recognition as internal double-strand breaks.  Telomerase is 
the reverse transcriptase responsible for maintaining telomeres (reviewed in [197]).  S. 
cerevisiae telomerase activity is regulated in the cell cycle; extension occurs in late S and 
G2/M phases but not in G1 phase [136,137], even though the catalytic core of the 
complex (Est2p and TLC1 RNA) is found to associate with the telomere during G1 phase 
in a manner dependent upon the TLC1-yKu interaction [54,55].  Est1p undergoes APC-
dependent degradation during G1 phase (Chapter II) that prevents its association with the 
telomere and telomerase complex.  Since Est1p is necessary and sufficient for the 
recruitment of Est3p to the telomere and into the complex, Est3p also does not robustly 
associate during G1 phase [81,101], though a small peak of telomere association has been 
observed [81].  The primary regulatory role for Est1p is to recruit telomerase to the site of 
action.  This recruitment function is accomplished through the direct protein-protein 
interaction between Est1p and the ssDNA binding protein Cdc13p [96-100].   
In Chapter II, I demonstrated that the APC is involved in the degradation of Est1p 
during G1 phase.  The APC is a multi-subunit E3 ubiquitin ligase that is critical for 
transit through the cell cycle.  Although the core subunits are constitutively expressed 
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[161,201,202], APC functionality oscillates due to phosphorylation states [208-210], 
exhibiting no activity in S and G2 phase, and high activity during mitosis and G1 phase 
[203].  The APC uses two evolutionarily conserved, WD40-domain containing activators, 
Cdc20p/Fizzy and Cdh1p/Hct1/Fizzy-related [204-206].  These activators bind directly to 
substrates via degradation motifs [173,178,181,182], the best characterized being the 
Destruction box (D-box: an arginine and leucine separated by any two amino acids, 
RxxL) and KEN-box [174,177,207].  One significant aspect of my research was 
examining the contribution of putative D-boxes (consensus RxxL) to Est1p half-life 
during G1 phase.  Six predicted D-boxes were systematically examined by disruption 
with alanine substitutions targeted to the conserved R and L of the consensus motif 
(AxxA; Figure 12).  When mutated, three of these D-boxes (1, 2 and 4) stabilized Est1p 
during G1 phase, arguing that these regions are important for degradation (Figure 12 and 
13).  However, each of these mutants failed to complement an est1Δ strain for telomere 
length, suggesting these alleles are compromised for an essential function of Est1p 
(Figure 15).  In this chapter, I characterize additional Est1p D-box mutants and 
demonstrate that there is no detectible consequence to stabilizing Est1p. 
 
Results and Discussion 
 
Stabilized alleles of est1 have short telomeres 
Three of the six putative D-boxes (1, 2 and 4) stabilized Est1p during G1 phase 
when mutated (RxxL → AxxA), but each of these mutants failed to complement an est1Δ 
strain for telomere length, suggesting these alleles are compromised for an essential 
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function of Est1p (Figure 15).  To identify est1 mutants that retained telomere 
maintenance, I tested a variety of other D-box mutations.  I made more modest 
substitutions in which the conserved Arg was changed to Lys to preserve the amino acid 
charge and expressed these changes either as a single mutant (KxxL or R→K) or with the 
conserved Leu simultaneously mutated (KxxA or R→K,L→A).  As shown in Figure 16, 
the charge-preserving substitutions of R→K (lanes 3 and 19) maintained nearly wild-type 
telomere length.  Though the combination with the L→A mutation showed telomere 
shortening (lane 4 and 20), this decrease was not as severe as that observed from the 
original (AxxA) mutations (lanes 7, 8, and 14), suggesting the charge of the residue is 
important for telomerase function.  Simultaneously mutating different D-boxes (lanes 9, 
11 and 15) results in constructs that are unable to complement the est1Δ (Figure 16), 
suggesting the four amino acids involved in the substitutions (AxxA + AxxA) are 
important residues for function and that the deleterious defects are additive.   
It became apparent that there is a strong negative correlation between stability and 
function in telomere length maintenance: mutation of predicted D-box 3 results in 
telomeres with near wild-type length, but the same mutations in D-box 1, 2, or 4 results 
in very short telomeres (Figure 17).  Furthermore, combining D-box 3 (AxxA) with D-
box 2 (AxxA) does not compromise telomere length more than that observed with the 
single D-box 2 mutations (Figure 16, compare lanes 8 and 10).  This result is consistent 
with D-box 3 exhibiting a wild-type half-life in G1 phase (Figure 12), suggesting it is not 
a true degron motif.  Therefore, I hypothesized that stabilization of Est1p was detrimental 
to telomere length maintenance.   
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Figure 16.  Mutation of Est1p D-boxes compromises telomere length. 
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Figure 17.  Negative correlation between Est1p half-life and telomere length. 
Telomere lengths were quantified from independent isolates of strain YKF810 (est1Δ) 
harboring plasmids pRS416-EST1 (WT) or the est1 D-box alleles indicated.  The mean 
change in telomere length compared to WT was determined and plotted against the 
average protein half-life.  A line of best fit is shown and demonstrates that as Est1p 
stability increases, telomere length decreases.  Two est1 D-box alleles (1+2 and 3+4) are 
represented by a red “X” at the value of their protein half-life (Figure 13); a telomere 
length measurement is uninformative due to survivor formation and maintenance of 
telomeres using a telomerase-independent mechanism (Figure 16, lanes 9 and 15).  
However, since these mutants result in survivor formation, the length can be interpreted 
to be shorter than that of any other mutant shown. * indicates DB2KxxL and ** indicates 
DB2KxxA. 
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If this hypothesis is correct, the wild-type length conferred by D-box 2 (KxxL) 
should be associated with a wild-type protein half-life in G1 phase, and the D-box 2 
(KxxA) mutation should have an increased half-life, since it shortens telomeres.  The 
protein half-life of these alleles measured with the promoter shut-off assay was consistent 
with this hypothesis (Figure 18).  However, the correlation is not absolute.  The D-box 2 
(KxxA) mutation stabilizes the protein similarly to the more severe mutation (AxxA) that 
shortens telomeres to a greater extent.  It is also important to note that the half-lives of 
alleles with mutations of the Arg residue only (AxxL or KxxL) are not significantly 
different from wild type.  These results suggest that mutation of the D-box 2 leucine 
residue is required to escape degradation, but I did not confirm this by mutation of the 
conserved Leu residue alone.  While most studies have examined simultaneous mutation 
of the Arg and Leu residues to test for D-box function, cyclin B can be stabilized with 
mutation of the Arg residue alone in vitro [175] and in vivo [233].  Therefore, I cannot 
exclude the possibility that the stabilization gained from these mutations is independent 
of degron recognition by the APC.   
The experiments presented above were conducted using a 2µ PGAL1-HA3-EST1 
plasmid (pKF600).  However, a plethora of experiments were conducted examining the 
contribution of these D-boxes to Est1p degradation using a different 2µ plasmid 
(pRS423-GAL1-HA3-EST1).  Although the EST1 ORF is identical on these two plasmids, 
I discovered that Est1p degradation is not regulated in the endogenous manner when 
expressed from the pRS423 plasmid: the protein is unstable throughout the cell cycle 
(Figure 8).  A number of additional D-box mutations were tested for effects on protein 
stability in G1 phase in the context of the pRS423 vector before the anomalous   
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Figure 18.  Degradation of Est1p requires the conserved leucine residue in D-box 2. 
Quantification of promoter shut-off assays, as described in Figure 12.  Alleles shown here 
are est1-DB2 (AxxA; described in Chapter II); est1-DB2R→A (AxxL); est1-DB2R→K 
(KxxL); and est1-DB2R→K,L→A (KxxA).  Differences from the wild-type (WT) EST1 
sequence are depicted in red.  Two distinct alleles of D-box 2 result in stabilization of the 
protein during G1 phase.  This stabilization depends upon simultaneous disruption of 
both conserved residues.  Bars represent the average half-life from three independent 
experiments; error bars are the deviation from the mean.  DB2 (AxxL) and DB2 (KxxL) 
are not statistically different from WT (p-values = 0.73 and 0.88, respectively).  DB2 
(KxxA) and DB2 (AxxA) are statistically different from WT (p-values = 0.0005 and 
0.012, respectively). 
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degradation pattern of this protein was discovered.  Although many of these constructs 
had effects consistent with results later obtained in pKF600, these data were not used in 
these studies.  The reason for the different behavior of the pRS423-expressed protein is 
unknown. 
 
Fusion of the CLB2 D-box to stabilized est1 alleles rescues telomere length  
If reduced degradation of Est1p during G1 phase is the cause of telomere 
shortening, I would expect telomere length to be rescued if the mutated protein was 
rendered unstable.  D-box motifs are transportable, conferring degradation to a normally 
stable protein [174,175,217].  Therefore, I fused the D-box from CLB2 (RLALNNVTN) 
to the N-terminus of the est1 alleles and examined the ability of the constructs expressing 
these alleles to maintain telomere length in an est1Δ background.  As shown in Figure 19, 
fusion of the CLB2 D-box to est1DB2AxxA or est1DB2KxxA rescued telomere length (compare 
lanes 11 and 19 with 10 and 18, respectively).  This rescue was specific to those 
mutations within D-box 2, since no rescue was achieved with fusion to est1DB1 (lanes 5 
and 6), est1DB1+2 (lanes 13 and 14), est1DB4 (lanes 21 and 22) or est1DB3+4 (26 and 27).  
Likewise, there was no telomere elongation when fused to wild-type EST1 (lanes 2 and 
3).  These results suggest that the telomere length defect can be rescued by restoring the 
presence of a D-box (and presumably degradation).  
To determine if this rescue depends upon the function of the CLB2 D-box, I 
mutated the conserved Arg, Leu, and Asn to Ala (RLALNNVTN→ALLANNVTA) and 
examined telomere length maintenance in an est1Δ strain.  As expected, the mutated 
fusion no longer rescued the D-box 2 alleles (Figure 19, lanes 12 and 20), arguing that an   
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Figure 19.  Fusion of the D-box from CLB2 rescues the telomere length of Est1DB2 alleles. 
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intact D-box is necessary.  However, interpretation of this result is complicated by the 
observation that telomere shortening also occurs with fusion of the mutated CLB2 D-box 
to wild-type EST1, despite the lack of effect from the WT CLB2 D-box sequence.  This 
shortening was specific to the mutated CLB2 D-box sequence (lanes 2-4).  I re-examined 
this effect using a less severe mutation of the CLB2 D-box, substituting only the Arg and 
Leu residues, but this construct also compromised telomere length when fused to wild-
type EST1 (data not shown).   
To confirm that the CLB2 D-box restored regulated degradation when fused to D-
box 2 mutants, I determined the half-life of the fusion proteins using the promoter shut-
off assay.  I also monitored the stability of the wild-type EST1 fusion, which was 
expected to show the same stability as Est1p alone.  Fusion of the CLB2 D-box to the est1 
allele mutated in D-box 4 did not restore telomere length, so the half-life of this fusion 
protein was determined as well.  As an additional control, I monitored the half-life of 
each protein when fused to the mutant CLB2 D-box.  Unexpectedly, the fusion of the 
CLB2 D-box sequence to the D-box 2 mutant protein did not lessen the protein half-life 
(Figure 20).  The half-life was also similarly unchanged for wild-type Est1p and D-box 4 
fusions.  Although the half-life remained unchanged when the mutated CLB2 D-box was 
fused to each of these proteins, this result is uninformative in light of the failure of the 
WT CLB2 D-box to promote protein degradation.  These results suggest that the telomere 
shortening observed upon stabilization of Est1p in the D-box 2 variants is not a simple 
consequence of Est1p overexpression or stability in G1 phase, since the fusion protein 
retains a long half-life yet exhibits a return to wild-type telomere length.  Perhaps the 
mutations in D-box 2 compromise Est1 protein folding that the fusion of the WT CLB2  
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Figure 20.  Fusion of the CLB2 D-box does not change protein half-lives. 
YKF802 containing pKF600 (GAL1-HA3-EST1) plasmids expressing either wild-type 
EST1 (WT) or the D-box (DB) mutated (RxxL to AxxA) est1 alleles indicated were 
treated as in Figure 8B, except strains were arrested with α-factor.  Also tested were 
alleles fused to either the wild-type (RLALNNVTN) or mutant (ALLANNVTA) CLB2 
D-box (denoted C2 or mutC2, respectively) at the N-terminus of the EST1 ORF.  Values 
for EST1, DB2 and DB4 represent the average half-life for three independent biological 
replicates; error bars are the standard deviation of the mean.  Values for the fusion 
constructs are from a single experiment.  
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D-box helps restore.  If so, the est1 alleles that failed to be rescued (Figure 19) may be 
more severely unfolded or compromised for an essential Est1p function.   
 
Overexpression of wild-type EST1 does not compromise telomere length 
 Telomere length is compromised when D-boxes are mutated and the Est1 protein 
is stabilized against degradation in G1 phase.  However, while I was able to rescue 
telomere length with fusion of the CLB2 D-box to Est1-DB2 mutants (Figure 19), the 
protein remained stabilized (Figure 20), suggesting that the stabilized protein is not the 
cause of telomere shortening.  Since increased resistance of a protein to degradation will 
result in increased steady-state levels of that protein, overproducing the protein may 
mimic the consequences of inappropriate stabilization.  Therefore, I examined the 
telomere length of strains that constitutively expressed EST1 under control of the ADH1, 
TEF, or GAL1 promoters to achieve different levels of overexpression.  As shown in 
Figure 21, introduction of a CEN vector expressing EST1 under control of the 
endogenous promoter did not change telomere length as compared to the empty vector 
control (lanes 1 and 2).  Introduction of a CEN vector expressing EST1 under the control 
of ADH1, TEF, or GAL1 promoters did not result in telomere shortening (lanes 3, 4, and 
5).  In fact, telomeres appear to have elongated.  Taken together, these data suggest there 
is no adverse consequence to preventing Est1p degradation during the cell cycle.  A 
discussion of the implication of these findings is in Chapter V. 
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Figure 21.  Overexpression of EST1 does not compromise telomere length 
maintenance. 
Four independent isolates from strain YKF802 (EST1) harboring pRS416 (empty vector: 
ev), pRS416-EST1 (EST1), or plasmids expressing EST1 under control of the 
overexpression promoters, ADH1, TEF, or GAL1.  Isolates were propagated for >100 
generations on glucose media, except for GAL1 which was propagated on galactose 
containing media.  DNA was extracted, digested with XhoI, Southern blotted, and probed 
with a randomly labeled telomeric DNA probe.  Positions of molecular weight markers 
(M) are indicated in kilobases (kb).  The horizontal dashed line indicates the average 
wild-type telomere length.  Note the smears do not decrease in length, indicating no 
telomere shortening occurred. 
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CHAPTER IV 
 
MATERIALS AND METHODS 
 
Ethics Statement 
All work with Xenopus laevis was approved by the Institutional Animal Care and 
Use Committee (IACUC) at Vanderbilt University Medical Center (protocol #M/07/143) 
and was carried out in accordance with their policies and guidelines.  Xenopus laevis 
were maintained by the Division of Animal Care (DAC) at Vanderbilt University’s 
Animal Care Facility, which provides both veterinary and husbandry services.  Animals 
were monitored on a daily basis by the DAC for signs of morbidity (e.g. lethargy, open 
sores, and excessive skin shedding).  Animals with these symptoms were subsequently 
euthanized by anaesthetic overdose with 0.05% Benzocaine absorbed through the skin, 
consistent with recommendations from the Panel on Euthanasia of the American 
Veterinary Medical Association.  
 
Yeast Strains and Plasmids 
S. cerevisiae strains used in this study are summarized in Table 1.  All gene 
disruptions were generated using PCR-mediated gene disruption [234]; primer sequences 
are shown in Table 2.  The bar1Δ::hisG in K1534 [212] was replaced by amplification of 
the bar1Δ::kanMX4 cassette from the yeast knockout collection [235] (Open Biosystems) 
to yield YKF800 using primer pair Bar1for/Bar1rev.  The bar1Δ::hisG of K1534, 
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MAY6810 and MAY6812 [217] was replaced by amplifying (primer pair 
Bar1::Hyg/Bar1::Hyg) the hphMX4 cassette from pAG32 [236] to yield YKF802, 
YKF806, and YKF807, respectively.  YKF803, YKF804, and YKF805 were constructed 
by amplification of the apc9, mnd2 and swm1 gene disruption cassettes (xxx::kanMX4) 
from the yeast knockout collection and integrated into YKF802, using primer pairs 
Apc9for/Apc9rev; Mnd2for/Mnd2rev; and Swm1for/Swm1rev, respectively.  A MYC13 
epitope tag was incorporated at the C terminus of the endogenous EST1 locus using 
plasmid pRS416-EST1-MYC13-hphNT1 [derived from pFA6a-13MYC-kanMX6 [237], 
pYM16 (hphNT1) [238] (Euroscarf), and pRS416 [239]; details of plasmid construction 
available by request].  Digestion of this plasmid with SacI and KpnI yielded a linear DNA 
molecule containing homology upstream and downstream of the EST1 chromosomal 
locus to allow one-step gene replacement.  Transformation of this fragment into strains 
YKF800 and YCM191 yielded YKF801 and YKF808, respectively.  YKF809 was 
generated by PCR-amplification of the cdh1Δ::KANR allele from MAY6812 and 
introduction into YKF808 by one-step gene replacement.  To yield YKF810, the 
endogenous EST1 locus was deleted in YKF802 by PCR-based gene deletion using 
plasmid pFA6a-kanMX6 [237]. 
Plasmids used in this study are summarized in Table 3.  Plasmid pKF600 is 
derived from pVL242RtoA [101] and differs by the arrangement of restriction sites to 
facilitate cloning of mutant alleles.  Individual D-box mutations (RxxL  AxxL, KxxL, 
KxxA or AxxA) were constructed by site-directed mutagenesis using the SOEing method 
(Figure 22) [240] and cloned into pKF600 using BamHI and SphI to yield the indicated 
pKF600-DB plasmids.  Simultaneous mutation of D-boxes 1+2, 2+3, 2+4, 3+4, 
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2+4R→K, or 5+6 was achieved by site-directed mutagenesis using a single mutant 
plasmid as the template in the PCR reaction.  Deletion alleles of EST1 were generated by 
PCR amplification of a portion of EST1 followed by insertion into pKF600 using primers 
M1209 + delta300; and E1Ndel7, E1Ndel15, E1Ndel25, E1Ndel35 or E150D + M1212.  
Plasmid pRS416-EST1 was generated by PCR amplifying the EST1 upstream promoter 
region, ORF, and downstream terminator region and cloning into pRS416.  Mutant est1 
alleles were introduced by subcloning from the pKF600 vector series, to yield the 
indicated pRS416-DB plasmids.  To generate CLB2 D-box fusion plasmids, EST1 was 
amplified using primer pair (Clb2Dboxinsert and EST1R264AL267Arev) or 
(Clb2mutDboxins and EST1R264AL267Arev) and cloned into pRS416-EST1 using 
BamHI and PflMI; this region was then subcloned into the pRS416-DB plasmids using 
HpaI.  The CDC16 complementing plasmid was generated in two steps: one primer pair 
(CDC16for + CDC16intrev) amplified the promoter region and first-half of the CDC16 
ORF while a second primer pair (CDC16intfor + CDC16rev) amplified the second-half 
of the CDC16 ORF and terminator.  These two fragments were sequentially cloned into 
pRS416 using XhoI/ClaI and ClaI/SacI to yield the complementing vector, pRS416-
CDC16.  This construct complemented the cdc16-123 ts allele for growth at 37°C.  The 
promoter region of pYM-N6 (ADH1), pYM-N18 (TEF) or pYM-N22 (GAL1) [238] was 
digested with SacI and XbaI, and cloned into pRS416; the EST1 ORF from pRS416-
EST1 was subcloned downstream of the promoter using BamHI and KpnI digestion to 
yield the pRS416-Promoter-EST1 plasmids.  To generate plasmid pKF601, the EST1 
ORF was PCR-amplified (Est1Fsefor + Est1Ascrev) and cloned into pCS2FA2R 
[derivative of pCS2; gift from Laurie Lee] at restriction sites FseI and AscI.  The EST1 
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ORF was PCR-amplified (M1209 + yEst1XbaRev) and cloned into pcDNA3.1-Hygro 
(Invitrogen) at restriction sites BamHI and XbaI to yield pKF602. 
 
 
 
 
 
 
 
 
Table 1.  S. cerevisiae strains used in this study. 
 
 Name  a Relevant Genotype Source 
 K1534 bar1Δ::hisG [212] 
 YKF800 bar1Δ::kanMX4 This study 
 YKF801 YKF800 EST1-MYC13 [hphNT1] This study 
 YKF802 bar1Δ::hphMX4 This study 
 K4438 K1534 cdc16-123 [212] 
 YKF803 YKF802 apc9Δ::kanMX4 This study 
 YKF804 YKF802 mnd2Δ::kanMX4 This study 
 YKF805 YKF802 swm1Δ::kanMX4 This study 
 MAY6810 bar1Δ::hisG clb2Δ::URA3 [217] 
 YKF806 bar1Δ:: hphMX4 clb2Δ::URA3 This study 
 MAY6812 bar1Δ::hisG clb2Δ::URA3 cdh1Δ:: KANR [217] 
 YKF807 bar1Δ::hphMX4 clb2Δ::URA3 cdh1Δ::KANR This study 
 YCM191 bar1Δ::URA3 cdc15-2 Gift from C. Hardy 
 YKF808 YCM191 EST1-MYC13 [hphNT1] This study 
 YKF809 YKF808 cdh1Δ::KANR This study 
 YKF810 YKF802 est1Δ::kanMX6 This study 
a All strains are derivatives of W303: MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-
11,15 ura3 ssd1 GAL 
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Table 2.  Primers used in this study. 
 
 Primer Name  a Primer Sequence 5’ → 3’ 
 Bar1::Hyg forward CATACCAAAATAAAAAGAGTGTCTAGAAGGGTCATATAGGCGCGCCA
GATCTGTTTAG 
 Bar1::Hyg reverse GATATTTATATGCTATAAAGAAATTGTACTCCAGATTTCATCGATGAA
TTCGAGCTCG 
 Bar1for GTTTATAGATAACGGCTCTTGC 
 Bar1rev CGTTTGGTTAGTTCAGCTAGG 
 M1209 ACTAGGATCCTAATGGATAATGAAGAAGTTAACGAAG 
 M1212 CCCTCACCATTACTTGTTCTCGCATGCTCAAGTAGGAGTATCTGGC 
 E1DB1RL2Afor-ext CAAGAACGCTGCAGCGCATGCGGATAAACATCTAACATC 
 E1DB1RL2Arev-ext GATGTTAGATGTTTATCCGCATGCGCTGCAGCGTTCTTG 
 E1DB2rightFor GCATATATCACGTTCGCTTGCTTCGCGGATGGTATACATTGCAAATCT
AC 
 E1DB2rightRev GTAGATTTGCAATGTATACCATCCGCGAAGCAAGCGAACGTGATATAT
GC 
 DB2R2Kfor GCATATATCACGTTTAAATGCTTCCTGG 
 DB2R2Krev CCAGGAAGCATTTAAACGTGATATATGC 
 DB2R2KL2Afor GCATATATCACGTTTAAATGCTTCGCGGATGGAATACATTGC 
 DB2R2KL2Arev GCAATGTATTCCATCCGCGAAGCATTTAAACGTGATATATGC 
 EST1R264AL267Afor CTGTATTTTTTTGAATTAGTAGCAGGAGCTGCAGTAAGGATTCCG 
 EST1R264AL267Arev CGGAATCCTTACTGCAGCTCCTGCTACTAATTCAAAAAAATACAG 
 E1DB4RL2Afor-ext CTCCTAATTTTCCGGAAGCAAGACGTGCGATGAAAAAATTGGC 
 E1DB4RL2Arev-ext GCCAATTTTTTCATCGCACGTCTTGCTTCCGGAAAATTAGGAG 
 E1DB4R2Kfor CCTAATTTTCCGGAAAAAAGACGGCTGATGAAAAAATTGG 
 E1DB4R2Krev CCAATTTTTTCATCAGCCGTCTTTTTTCCGGAAAATTAGG 
 E1DB4R2KL2Afor CCTAATTTTCCGGAAAAAAGACGTGCGATGAAAAAATTGG 
 E1DB4R2KL2Arev CCAATTTTTTCATCGCACGTCTTTTTTCCGGAAAATTAGG 
 E1DB5RL2ADMfor GATTAAGTCATATGCATCTATTGCGCAGTACACTC 
 E1DB5RL2ADMrev GAGTGTACTGCGCAATAGATGCATATGACTTAATC 
 E1DB6RL2Afor-ext GCCACAGGCCGAAAGCTAGCTATGCTTTTAGAGAAGATATTATTTTCA
GG 
 E1DB6RL2Arev-ext CCTGAAAATAATATCTTCTCTAAAAGCATAGCTAGCTTTCGGCCTGTG
GC 
 Clb2Dboxinsert CACATGCCACCGGATCCTAATGAGATTGGCTTTGAACAACGTTACTAA
TGATAATGAAGAAG 
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Table 2, continued 
 
 Primer Name  a Primer Sequence 5’ → 3’ 
 Clb2mutDboxinsert CACATGCCACCGGATCCTAATGGCATTGGCTGCCAACAACGTTACTGC
TGATAATGAAGAAG 
 Est1 Fse for GATTGGGGCCGGCCATGGATAACGAAGAAGTTAACGAAG 
 Est1 Asc rev GATTGGGGCGCGCCTCAAGTAGGAGTATCTGGCAC 
 yEst1XbaRev GGACTCTAGATCAAGTAGGAGTATCTGGCACTTG 
 CDC16for GCTCCTCGAGCGCTATGCGATGAAAGCATTG 
 CDC16intfor CCTTCTGTCGCATCGATTAGCGGAAAC 
 CDC16intrev GTTTCCGCTAATCGATGCGACAGAAGG 
 CDC16rev GGACGAGCTCGGGAAAGAAGAACGGCAAGGAG 
 Apc9 forward GAACAGGGAACTAGGTTTGGAAG 
 Apc9 reverse GTATAGAAAACGCATATCAACTG 
 Mnd2 forward CTGTGCTACGCCACATCAGAATAC 
 Mnd2 reverse CTAAGCACTTTTGGTGCACTTGTG 
 Swm1 forward CGTGAGAGAAGGGAGAATAATATC 
 Swm1 reverse GTGCATAGTACCCATACACCAC 
 delta300 GTCCGCATGCTCAATCGAAACTTCCCATTGTGGC 
 E1Ndel7 GCTAAGGATCCTAGAAGAATGTATGAGATTATTTTTC 
 E1Ndel15 GCTAAGGATCCTAAAGAACGCTCGTGCGCATCTG 
 E1Ndel25 GCTAAGGATCCTAACATCAAGGTTGACATGCGATG 
 E1Ndel35 GCTAAGGATCCTAGCATATATCACGTTCAGATGC 
 E150D GCTAAGGATCCTAGCGACTAGGTTTCTCGAAGAGC 
a Underlined sequence indicates restriction enzyme recognition site. 
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Table 3.  Plasmids used in this study. 
 
 Name Relevant Sequence or description Source 
 pVL242RtoA PGAL1-HA3-EST1 [LEU2 2µ] [101] 
 pKF600 PGAL1-HA3-EST1 [LEU2 2µ] This study 
 pKF600-DB1 PGAL1-HA3-est1D-box 1 (RAHL  AAHA)  This study 
 pKF600-DB2 PGAL1-HA3-est1D-box 2 (RCFL  ACFA)  This study 
 pKF600-DB3 PGAL1-HA3-est1D-box 3 (RGAL  AGAA)  This study 
 pKF600-DB4 PGAL1-HA3-est1D-box 4 (RRRL  ARRA)  This study 
 pKF600-DB1+2 PGAL1-HA3-est1D-box 1+2  This study 
 pKF600-DB3+4 PGAL1-HA3-est1D-box 3+4  This study 
 pKF600-DB5+6 PGAL1-HA3-est1D-box 5+6 (RSIL  ASIA and RSYL  ASYA)  This study 
 pKF600-C300 PGAL1-HA3-est1CΔ300  This study 
 pKF600-N7 PGAL1-HA3-est1NΔ7  This study 
 pKF600-N15 PGAL1-HA3-est1NΔ15  This study 
 pKF600-N25 PGAL1-HA3-est1NΔ25  This study 
 pKF600-N35 PGAL1-HA3-est1NΔ35  This study 
 pKF600-N50 PGAL1-HA3-est1NΔ50  This study 
 pKF600-DB2R2A PGAL1-HA3-est1D-box 2 (RCFL  ACFL)  This study 
 pKF600-DB2R2K PGAL1-HA3-est1D-box 2 (RCFL  KCFL)  This study 
 pKF600-DB2R2KL2A PGAL1-HA3-est1D-box 2 (RCFL  KCFA)  This study 
 pKF600-C2 PGAL1-HA3-Clb2DB-EST1  This study 
 pKF600-C2-DB2 PGAL1-HA3-Clb2DB- est1D-box 2 This study 
 pKF600-C2-DB4 PGAL1-HA3-Clb2DB- est1D-box 4 This study 
 pKF600-mutC2 PGAL1-HA3-Clb2db-EST1  This study 
 pKF600-mutC2-DB2 PGAL1-HA3-Clb2db- est1D-box 2 This study 
 pKF600-mutC2-DB4 PGAL1-HA3-Clb2db- est1D-box 4 This study 
 pRS416 Empty vector [URA3 CEN] [239] 
 pRS416-EST1 PEST1-EST1 This study 
 pRS416-DB1 PEST1- est1D-box 1 (RAHL  AAHA) This study 
 pRS416-DB2 PEST1- est1D-box 2 (RCFL  ACFA) This study 
 pRS416-DB3 PEST1- est1D-box 3 (RGAL  AGAA) This study 
 pRS416-DB4 PEST1- est1D-box 4 (RRRL  ARRA) This study 
 pRS416-DB1+2 PEST1- est1D-box 1+2 This study 
 pRS416-DB3+4 PEST1- est1D-box 3+4 This study 
 pRS416-DB2R2K PEST1- est1D-box 2 (RCFL  KCFL) This study 
 pRS416-DB2R2KL2A PEST1- est1D-box 2 (RCFL  KCFA) This study 
 pRS416-DB2+3  PEST1- est1D-box 2+3 This study 
 pRS416-DB2+4 PEST1- est1D-box 2+4 This study 
 pRS416-DB2+4R2K PEST1- est1D-box 2+4 (RRRL  KRRL) This study 
 pRS416-DB4R2K PEST1- est1D-box 4 (RRRL  KRRL) This study 
 pRS416-DB4R2KL2A PEST1- est1D-box 4 (RRRL  KRRA) This study 
 pRS416-C2-EST1 PEST1- Clb2DB-EST1 This study 
 pRS416-C2-DB1 PEST1- Clb2DB-est1D-box 1 This study 
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Table 3, continued 
 
 Name Relevant Sequence or description Source 
 pRS416-C2-DB2 PEST1- Clb2DB-est1D-box 2 This study 
 pRS416-C2-DB1+2 PEST1- Clb2DB-est1D-box 1+2 This study 
 pRS416-C2-DB2R2KL2A PEST1- Clb2DB-est1D-box 2 (RCFL  KCFA) This study 
 pRS416-C2-DB4 PEST1- Clb2DB- est1D-box 4 This study 
 pRS416-C2-DB3+4 PEST1- Clb2DB-est1D-box 3+4 This study 
 pRS416-mutC2-EST1 PEST1- Clb2db-EST1 This study 
 pRS416-mutC2-DB1 PEST1- Clb2db-est1D-box 1 This study 
 pRS416-mutC2-DB2 PEST1- Clb2db-est1D-box 2 This study 
 pRS416-mutC2-DB1+2 PEST1- Clb2db-est1D-box 1+2 This study 
 pRS416-mutC2-DB2R2KL2A PEST1- Clb2db-est1D-box 2 (RCFL  KCFA) This study 
 pRS416-mutC2-DB4 PEST1- Clb2db-est1D-box 4 This study 
 pRS416-mutC2-DB3+4 PEST1- Clb2db-est1D-box 3+4 This study 
 pRS416-ADH-EST1 PADH1-EST1 This study 
 pRS416-TEF-EST1 PTEF-EST1 This study 
 pRS416-GAL1-EST1 PGAL1-EST1 This study 
 pRS416-CDC16 PCDC16-CDC16 This study 
 pKF601 PSp6-EST1  This study 
 pCS2FA2R-Cyclin B PSp6-CycB Gift from L. Lee 
 pKF602 PT7-EST1  This study 
 pRSET-PDS1 PT7-PDS1    [159] 
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Figure 22.  Construction of est1 D-box mutant alleles by SOEing PCR. 
To introduce site-directed mutations within the six putative EST1 D-boxes, 
complementary primer pairs were designed (colored arrows).  PCR round 1 consists of 
two reactions 1) outer forward primer (M1209) and inner reverse D-box primer, and 2) 
inner forward D-box primer and outer reverse primer (M1212).  The second round of 
PCR uses the two outer primers (M1209 and M1212) and the two DNA products from 
round 1, which anneal via their complementary region.  The end product is the mutated 
(asterisks) full-length ‘stitched’ product, which was then cloned into pKF600 using 
BamHI and SphI restriction enzyme sites.  est1-DB3 is shown as an example.  The primer 
pairs used were: E1DB1RL2A; E1DB2right; DB2R2K; DB2R2KL2A; 
EST1R264AL267A (DB3); DB4RL2A; DB4R2K; DB4R2KL2A; E1DB5RL2ADM; 
E1DB6RL2A, shown in Table 2.  
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Determination of Est1p Steady-State Levels During Cell Cycle Arrest 
Strains YKF800 (bar1Δ) and YKF801 (bar1Δ EST1-MYC13) were grown 
asynchronously at 30°C to OD600 ≈ 0.5 and either left untreated (asynchronous) or treated 
with α-factor (0.5 µM final concentration; Zymo Research), hydroxyurea (15 mg/ml) 
final concentration; Sigma Aldrich), or nocodazole (10 mg/ml nocodazole in DMSO to a 
final concentration of 10µg/ml; Sigma Aldrich) for a minimum of 2.5 hrs.  When 95% of 
the population exhibited the characteristic morphologies, cells were harvested and whole-
cell extract prepared as described [61]; protein concentrations were determined by 
Bradford assay (Bio-Rad).  Equal amount of protein extract (100-150µg) were separated 
by 10% Tris-Glycine (Bio-Rad) and 7% NuPAGE Bis-Tris (Invitrogen) gels and 
transferred to Hybond P (GE Healthcare).  Each membrane was blocked with 5% 
milk/phosphate-buffered saline pH 7.4 with 0.05% Tween (PBS-T) followed by 
incubation with primary antibodies overnight at 4°C.  Antibody dilutions were as follows: 
Clb2-1:6000 dilution rabbit polyclonal y-180 (Santa Cruz); Actin-1:1200 goat polyclonal 
C-11 (Santa Cruz); 1:1000 mouse monoclonal mAbcam8224 (Abcam); and MYC-1:333 
murine monoclonal Ab.1 (OP10L, EMD Biosciences).  Bis-Tris gels were utilized for 
Est1-MYC13p detection because the protein co-migrated with a background band that 
could not be resolved using the 10% Tris-glycine gels.  Secondary antibodies were 
1:10000 dilutions of peroxidase-conjugated goat anti-mouse [Millipore], goat anti-rabbit 
[Millipore], and donkey anti-goat [sc-2020; Santa Cruz].  ECL Plus Western Blotting 
Detection system (GE Healthcare) was used for detection. 
 For flow cytometry analysis, cells were treated as described in [241], except that 
samples were digested overnight with RNase A at 37°C instead of pepsin.  Fluorescence 
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and light scattering were monitored for 10,000 cells using a 5-laser BD LSRII.  To 
eliminate any size-bias, samples were not gated and all events are plotted in the 
histograms presented. 
 
Overexpressed Est1p Stability Assays and Half-Life Quantification 
Strains YKF802 (wild type), YKF803 (apc9Δ), YKF804 (mnd2Δ), YKF805 
(swm1Δ) containing plasmid pVL242RtoA (GAL1-HA3-EST1) or variants of pKF600 
(GAL1-HA3-EST1: WT; DB1; DB2; DB2R→A; DB2R→K; DB2R→K,L→A; DB1+2; 
DB3; DB4; DB3+4; DB5+6; CΔ300; NΔ7; NΔ15; NΔ25; NΔ35; NΔ50) were assayed as 
described in [101], except using hydroxyurea (15 mg/ml final concentration; Sigma 
Aldrich) where indicated.  Also examined were constructs with either the wild-type 
(RLALNNVTN) or mutant (ALLANNVTA) CLB2 D-box fused to the N-terminus of the 
WT, DB2 or DB4 gene.  For temperature-sensitive experiments, K4438 (cdc16-123) 
containing plasmid pKF600 and either a complementing vector (pRS416-CDC16) or 
empty vector (pRS416) were assayed as in [101], except for growth in 2% (w/v) raffinose 
media lacking leucine and uracil (-Leu -Ura) and a shift to the restrictive temperature 
(37°C) at the time of galactose addition.  Samples were separated on 10% tris-glycine 
SDS-PAGE gels (Bio-Rad) and transferred to Hybond P (GE Healthcare).  Membranes 
were blocked with 5% milk/phosphate-buffered saline pH 7.4 with 0.05% Tween (PBS-
T) followed by incubation with primary antibodies (HA: 1:500 dilution [murine 
monoclonal HA.11; Covance]; Clb2 and Actin, as above) overnight at 4°C.  Secondary 
antibodies and detection system are as described above.  For half-life determination, the 
signal obtained for HA3-Est1p at each time point was corrected for input (actin), 
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normalized to the starting amount (time 0), base-e log-transformed, and plotted against 
time.  The slope was determined using a linear best-fit line and used to calculate the half-
life by T1/2 = ln(2)/slope, as described in [242]. 
 
cdc15-2 Block and Release 
1000 ml cultures of strains YKF808 (cdc15-2 EST1-MYC13) and YKF809 (cdc15-
2 cdh1Δ EST1-MYC13) were grown asynchronously at 23°C to OD600 ≈ 0.4 and then 
shifted to the restrictive temperature (37°C) in an air incubator for 3.5 hrs or until >95% 
of the population was arrested in mitosis, as determined by observation of the bud index.  
Cultures were released from the cdc15-2 arrest by rapid cooling in an ice water bath to 
23°C (time 0) and returned to a 23°C air incubator for the remainder of the experiment.  
Samples (125 ml) were harvested at 20 min intervals following release and whole-cell 
extract was prepared as described [61].  Synchrony of the release was monitored by bud-
index and flow cytometry.  YCM191 (untagged; cdc15-2) was grown as above and 
harvested following incubation at 37°C.  Equal amounts of protein (120 µg), as 
determined by Bradford assay (Bio-Rad), were analyzed by Western blotting as described 
above.  Est1-MYC13p and Clb2p signal intensity at each time point was normalized to 
protein input (actin) and starting amount (time 0).  Samples from each assay were 
analyzed by Western blot two to three times and the quantified results were averaged to 
give yield a value for that independent assay.  Averages determined from the independent 
biological replicates (WT = 4, cdh1Δ = 3) were subsequently averaged to yield the values 
reported in Figure 11.  Standard deviation of the mean was determined across the 
independent biological replicates. 
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In vitro Assays of Est1p Stability/Ubiquitination 
Xenopus laevis egg extracts were prepared in a manner similar to that previously 
described [177,243].  Briefly, eggs from Human chorionic gonadotropin (HCG)-injected, 
pregnant mare serum gonadotropin (PMSG)-primed frogs were collected and washed in 
1x Marc’s modified ringer (MMR) solution.  Eggs were dejellied with 2% cysteine and 
then washed into extract buffer (XB) and XB containing protease inhibitors.  A 30 sec 
packing spin at 1000 rpm at 2°C was performed, followed by a crushing spin at 13,000 
rpm for 5 min at 2°C.  The cytoplasmic layer was collected and subjected to a clarifying 
spin also at 13,000 rpm for 5 min at 2°C.  The clarified cytoplasmic layer was collected.  
After addition of protease inhibitors, energy mix [243] and cytochalasin B, extracts were 
either frozen in liquid nitrogen (− CDH1) or activated with addition of in vitro 
transcribed human Cdh1-MYC6 RNA (+ CDH1) for 2 hrs at room temperature prior to 
flash freezing, and stored in liquid nitrogen.  An anti-MYC Western blot confirmed 
successful translation of Cdh1-MYC6 RNA.  35S-labeled substrates (S. cerevisiae Est1p, 
Drosophila Cyclin B, and firefly luciferase) were produced using the TNT Sp6 Quick 
coupled in vitro transcription/translation (IVT) kit (Promega).  Additional Cdh1-MYC6 
protein was produced using the TNT Sp6 High-Yield Wheat Germ Protein Expression 
System (Promega), added (2 µL) to thawed + CDH1 extract, and incubated at room 
temperature for 15 mins. Inactive (− CDH1) and active (+ CDH1) extracts  (10 µL) were 
incubated at room temperature with 1-2 µL recombinant substrates, energy mix, and 
ubiquitin (Sigma).  Samples (2 µL) were taken at 0, 30, 60 and 90mins and frozen in 
liquid nitrogen.  Samples were separated on 10% Tris-glycine (Bio-Rad) SDS-PAGE gels, 
fixed, dried and exposed to a phosphor-imager screen. 
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APC/C ubiquitination assays were adopted and modified from [244]. 35S-labeled 
substrates and unlabeled S. cerevisiae Cdh1 were prepared using TNT T7 Quick coupled 
in vitro transcription/translation (IVT) (Promega).  Each ubiquitination reaction contained 
approximately 10 ng of APC, 1 µl of 35S-labeled substrate, and 2 µl of Cdh1 in a 10 µl 
reaction volume with 40 mM Tris-HCl pH 7.5, 10 mM MgCl2, 0.6 mM DTT, 2.7 mM 
ATP, 6.6 µg of methyl-ubiquitin, 500 ng of Ubc4, 200 ng of ubiquitin aldehyde (Enzo 
Life Science), 2 mM LLnL (N-acetyl-Leu-Leu-Norleu-aldehyde; Sigma).  Reactions 
were incubated at room temperature for 60 mins and were analyzed by 8% SDS-PAGE.  
Gels were fixed and stained with Coomassie Blue followed by drying and exposure to 
BioMax MR Film (Kodak). 
 
Southern Blotting 
For complementation tests, strain YKF810 (est1Δ) containing pRS416-EST1 was 
grown in non-selective media, plated on 5-fluroorotic acid (5-FoA) to select for loss of 
the complementing plasmid, and then transformed using the standard lithium acetate 
method with an empty vector (pRS416), complementing plasmid (pRS416-EST1), or 
variants of pRS416 expressing mutant est1 alleles (DB1; DB2; DB2R→K; 
DB2R→K,L→A; DB1+2; DB3; DB4; DB4R→K; DB2+4R→K; DB4R→K,L→A; 
DB3+4; DB2+3, DB2+4).  Also examined were constructs with either the wild-type 
(RLALNNVTN) or mutant (ALLANNVTA) CLB2 D-box fused to the N-terminus, 
including wild-type; DB1; DB2; DB1+2; DB2R→K,L→A; DB4; and DB3+4.  
Independent transformants were restreaked three times on selective media and then 
grown in liquid culture.  DNA was extracted by glass bead lysis [245], digested with 
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XhoI, and Southern blotted as described in [62].  Mean telomere restriction fragment 
length was calculated from densitometric scans by Image J software and a linear log 
curve derived from the molecular weight markers.  To determine the difference in length, 
mutant lengths were compared to the WT control run on the same gel. 
For analysis of telomere length upon overexpression of EST1, strain YKF802 
(wild type) was transformed with an empty vector (pRS416) or plasmids expressing EST1 
under various promoter strengths, including the endogenous EST1 promoter (pRS416-
EST1), ADH1 promoter (pRS416-ADH-EST1), TEF promoter (pRS416-TEF-EST1), or 
GAL1 promoter (pRS416-GAL-EST1).  Independent transformants were treated as 
above, except for the pRS416-GAL1-EST1 isolates which were cultured with media 
containing 2% raffinose + 1% galactose to induce expression.  As a control, this media 
treatment was tested on the control strain (pRS416) and did not affect telomere length 
(data not shown). 
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CHAPTER V 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
  
 Telomeres are critical for the maintenance of genome integrity, ensuring the 
faithful replication of chromosomes and protecting chromosome ends from damage. 
Telomerase activity is temporally regulated; telomere extension only occurs during late S 
and G2/M phases [137].  One mechanism that contributes to this restriction is the 
regulation of complex assembly.  During G1 phase, Est1 protein levels are regulated 
through a proteasome-dependent pathway [101], arguing that the amount of Est1p 
fluctuates due to protein degradation.  Though Est3p levels do not decrease during G1 
phase, the protein does not associate with the telomerase complex or telomeres [81,101].  
The regulated assembly of Est3p with other telomerase subunits depends upon Est1p, 
since EST1 overexpression during G1 phase is sufficient to recruit Est3p [101].  
Likewise, Est1p is necessary for Est3p association with the telomere [81].  Since complex 
assembly is necessary for in vivo activity, understanding how these subunits assemble is 
critical.  Therefore, in this thesis, I focused on the regulation of telomerase assembly by 
determining the mechanism that targets Est1p for degradation during G1 phase (Chapters 
II and III). 
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Est1p Undergoes Regulated Degradation  
 
Est1p levels fluctuate during the cell cycle 
Though it was known that Est1p levels are low during G1 phase as compared to 
G2/M phase [101], the remainder of the cell cycle was unexamined.  Since telomere 
replication and extension occur during late S phase, I was interested in determining when 
Est1p levels begin to increase.  Therefore, I monitored Est1p levels throughout the cell 
cycle following a release from a mitotic arrest using the cdc15-2 ts allele.  Est1p levels 
rose as cells began transit through S phase (Figure 11), suggesting that complex assembly 
may occur near the G1/S phase transition, prior to telomere elongation (late S phase).  
However, previous work had shown that assembly of the telomerase complex is not the 
sole determinant of telomerase activity [101].  One possibility is that the telomere is 
inaccessible to telomerase during G1 phase.  Therefore, it would be informative to 
determine if the telomerase protein subunits (Est1-3) associate with the telomere by ChIP 
when Est1p levels are artificially increased during G1 phase.  To increase Est1p levels, 
the protein can be overexpressed using a constitutive (ADH1 or TEF) or inducible 
(GAL1) promoter.  Likewise, overexpression can also be achieved by using a stabilized 
allele of Est1p (see below).  
 
The mechanism of Est1p degradation 
Since the timing of Est1p degradation is similar to the known APC-substrate 
Clb2p (Figure 8), I investigated the contribution of the APC to Est1p degradation.  I 
found that deletion of non-essential subunits or perturbation of APC activity using ts 
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alleles increased the half-life of overexpressed Est1p (Figure 9).  Likewise, endogenously 
expressed Est1p was not degraded once released from the cdc15-2 arrest when the APC-
activator CDH1 was deleted (Figure 11).  These results strongly argue that the APC 
contributes to Est1p degradation.  In support of the hypothesis that the APC recognizes 
Est1p directly, I found that several APC degron motifs (D-boxes) within EST1 are 
necessary for protein degradation (Figures 12 and 13).  However, when I expressed Est1 
in RRL and monitored degradation in Xenopus egg extract that had been activated with 
exogenously added Cdh1 protein, no degradation was detected over a 60min time-course 
(Figure 14A).  In collaboration with David Barford’s laboratory, it was also demonstrated 
that Est1p is not ubiquitinated by the S. cerevisiae APC in vitro (Figure 14B).  
Collectively, the in vitro results suggest that Est1p is not directly recognized by the APC, 
a finding that appears inconsistent with the identification of D-box sequences that 
influence Est1p stability in vivo. In the following sections I will elaborate on the evidence 
supporting each possibility (Est1p either is or is not a direct target of the APC) and 
propose further experiments that may offer clarity between the two interpretations.   
 
Possibility #1:  Est1p is a direct target of the APC 
If Est1p is a direct target of the APC, then one must postulate that it is the 
negative results in the in vitro assays that are misleading.  One possibility is that the 
recombinant Est1 protein produced in RRL is not recognized by the APC because either 
the folding and/or modifications of the protein are non-native. While I have not shown 
that the recombinant Est1 protein produced in RRL is either active or folded, there is 
evidence that an unfolded structure can nevertheless be recognized by APC machinery.  
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A fragment of human Cyclin B and S. cerevisiae Pds1p/securin that contains the degron 
motif recognized by the APC was purified from E. coli and found to natively exist in an 
unstructured state [246].  These and similar fragments are ubiquitinated and/or degraded 
in an APC-dependent manner [175,246,247], suggesting these unfolded structures are 
sufficiently recognized.  Likewise, the structure of APCCdh1p in complex with a short 
peptide containing the D-box or KEN-box degrons of known substrates was determined 
by electron microscopy (EM) [171,185].  These data suggest the degron regions can exist 
in an extended or relatively unfolded conformation; therefore, unfolding of Est1p may 
not be a significant concern.  
A more likely possibility is that the RRL-produced Est1p does not mimic 
appropriate post-translational modification(s) necessary for APC-mediated recognition 
and subsequent degradation/ubiquitination in vitro.  Phosphorylation of critical residues 
located near the D-box of mammalian Cdc6 protein [190] and yeast Pds1p/securin [191] 
disrupts recognition by the activator subunits (Cdc20p and Cdh1p), therefore inhibiting 
APC-dependent degradation.  Likewise, an N-terminal region termed the A-box 
(sequence: RILGPSNVPQRV) in the eukaryotic mitotic kinase Aurora A must be de-
phosphorylated at mitotic exit to allow destruction in a D-box and APC-dependent 
manner [229].  On the other hand, acetylation of mammalian cyclin A [248] and BubR1 
[249] or farnesylation of the kinetochore protein Cenp-F [250] promotes APC-mediated 
degradation.  These examples highlight the recent observations that post-translational 
modifications can play important positive and negative regulatory roles in APC-mediated 
degradation.  The cell-free RRL system is capable of some post-translational activity, 
including phosphorylation, farnesylation, isoprenylation, acetylation, and adenylation 
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(Promega; [251]).  Therefore, the RRL produced Est1p may exhibit inhibitory 
modifications that normally undergo regulated removal in vivo, or lack necessary 
modifications for degradation.  To examine these possibilities, the RRL-produced Est1p 
can be pre-treated with enzymes capable of producing (kinases, farnesyltransferases, 
acetyltransferases, etc.) or removing (phosphatases, inhibitors, etc.) these modifications 
and re-tested in the in vitro degradation/ubiquitination assays (although there is always 
the caveat that the modifications may not be on the appropriate residue). 
Another approach to address this issue is to utilize Est1p protein that has been 
purified from yeast. Although the human homolog of Est1p has been successfully 
produced in RRL [252,253], there are no published reports of recombinant S. cerevisiae 
Est1p being produced in RRL or E. coli.  However, several groups [81,94,100] have 
successfully purified Est1p from S. cerevisiae, and demonstrated that the protein thus 
isolated stimulates telomerase activity [94], directly associates with the ssDNA binding 
protein Cdc13p [100], and interacts with Est3p in vitro [81].  The in vitro 
ubiquitination/degradation assays could be repeated with Est1p purified from yeast 
because this protein is likely to be folded correctly and contain native modifications. 
It is important to note, however, that Est1p reportedly does not undergo 
phosphorylation.  These experiments utilized the Phos-tag technique wherein a chemical 
is added to the gel to retard the mobility of phosphorylated proteins [81].  However, a 
more thorough approach would be to perform 2-dimensional gel electrophoresis, stable 
isotope labeling by amino acids in cell culture (SILAC) and mass spectrometry (MS), or 
subject immunoprecipitated Est1p to in vitro kinase assays using purified kinases.  
Candidates to examine include the cyclin-CDK/Cdc28p and DDK (Cdc7/Dbf4) kinase 
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complexes, since these are active when Est1p levels are elevated and inactive at the time 
of Est1p degradation [254].  Since there have been no published reports examining other 
post-translational modifications on Est1p, the modification state of Est1p could be an 
intriguing avenue to explore since it could regulate telomerase complex assembly.   
 
Possibility #2: Est1p is an indirect target of the APC 
The alternative explanation posits that the in vitro results are robust and that Est1p 
cannot be directly recognized by the APC.  In this model, APC activity must be necessary 
for the degradation of an unknown substrate that in turn affects the stability of Est1p.  
Possible steps at which this indirect effect could be manifested are discussed below.  Of 
the evidence that I have presented for a role of the APC in Est1p stability in vivo, the 
results that argue for direct recognition of Est1p are those in which potential D-box 
sequences were identified.   
I mutated six putative D-boxes and examined the effect of these mutations on the 
half-life of Est1p during G1 phase.  Mutations in D-boxes 1, 2, and 4 stabilized Est1p, 
consistent with the idea that Est1p is a direct APC substrate and that these regions are 
necessary for recognition by the APC.  However, other explanations for these effects are 
plausible.  Charlene Hawkins, a graduate student in our lab, recently identified a nuclear 
localization sequence (NLS) that includes the residues of D-box 4.  When these residues 
are mutated to alanine, nuclear import of Est1p is compromised and telomeres shorten.  
However, nuclear localization and telomere shortening can be nearly fully rescued by the 
fusion of the SV40-NLS sequence, arguing that the cause of telomere shortening is mis-
localization (unpublished).  Since the APC is localized to the nucleus [203,255], 
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stabilization that results from mutation of these residues may be due to sequestration of 
Est1p in the cytoplasm, away from the degradation machinery.  If true, the half-life of 
Est1-DB4 mutants should be restored to wild type when the mutant protein is fused to the 
SV40-NLS.  Consistent with this hypothesis, the Cin8p spindle motor protein requires 
nuclear localization for APC-mediated degradation [217].  While defects in nuclear 
localization may account for the effect of mutations in putative D-box 4, the stabilization 
of mutations in D-boxes 1 and 2 cannot be attributed to mislocalization based on the 
known NLS sequences (Hawkins and Friedman, unpublished data).   
The experiments presented here to monitor the stability of Est1 variants with D-
box mutations were done using promoter shut-off assays in which Est1p is expressed at 
levels much higher than those encountered endogenously.  Although such experiments 
are commonly used in the field, there is a concern that mechanisms leading to 
degradation of highly overexpressed protein may differ from those acting upon native 
Est1p (this issue is discussed in more detail below).  I attempted to address this issue by 
re-expressing the mutated Est1 proteins from the endogenous EST1 locus.  Contrary to 
expectation, I did not observe any accumulation of Est1 protein in G1 phase arrested cells 
(data not shown).  While this result could indicate that the D-boxes identified using 
overexpressed constructs are not important at endogenous expression levels, there are 
some concerns with the interpretation of this result as well.  When endogenous protein 
levels are examined in G1 phase, cells are held at the G1 arrest for several hours, as 
compared to a normal G1 phase transit time of no more than 30 minutes.  Therefore, 
stabilized protein with a half-life that increases from 10 mins to 20-30 mins may undergo 
several rounds of degradation during the incubation period, significantly depleting the 
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protein pool.  A similar finding has been reported for Clb2p.  Using a promoter shut-off 
assay, Clb2p is stabilized when SWM1 is deleted.  However, endogenously expressed 
Clb2p is not detectible in G1 arrested swm1Δ cells [196,218].  Upon release from a G1 
arrest in swm1Δ cells, Clb2p does not oscillate during the subsequent cell cycle as seen in 
wild-type cells [218].  This data suggests the elongated G1 phase may overemphasize the 
amount of protein decline, even if the protein half-life is significantly longer.  Therefore, 
I suggest that monitoring the oscillation patterns following synchronous release from an 
arrest is a more informative experiment.  In this type of experiment, the cells proceed 
through a normally timed cell cycle and decreases/increases in protein steady-state levels 
should not be artificially affected. 
 
Potential Mechanisms Through Which the APC Could Indirectly Affect Est1p 
Expression 
I have presented evidence that the APC affects Est1p degradation in vivo, though 
it remains possible that this is through an indirect mechanism.  The APC could degrade a 
protein that is in turn responsible for regulated Est1p protein stability.  This possibility 
has a precedent in the literature.  At the metaphase-to-anaphase transition, APCCdc20p 
ubiquitinates Pds1p/securin, releasing Esp1p/separase to cleave Scc1p/cohesin and 
initiate sister-chromatid separation (reviewed in [176]).  The Scc1p cleavage product then 
undergoes rapid degradation through the N-end rule pathway [256].  Perturbation of the 
APC using the temperature-sensitive allele cdc23-1 increases the half-life of the Scc1 
protein [257], through an indirect effect of preventing Pds1p/securin degradation.  In such 
a case, Est1p would therefore not be considered a direct target of the APC, but would still 
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be degraded in an APC-dependent pathway.  This conclusion is supported by both the in 
vitro and in vivo data.  To identify the true protease responsible for Est1p degradation, a 
genetic screen of known E3 ubiquitin ligases could be used.   
A second possibility is that the APC affects expression of Est1p at the RNA level.  
The cdc15-2 block and release experiment shows a reproducible decrease in Est1 and 
Clb2 protein as cells proceed through G1 phase.  However, since Est1p transcript levels 
also decrease during G1 phase (at least during an arrest) [101], the decrease in protein 
could be affected by decreasing RNA levels.  One possibility is that the APC degrades a 
protein that in turn affects Est1p RNA expression or stability. If this is the case, Northern 
blot analysis of samples taken after release from the cdc15-2 block will show that the 
Est1p RNA is stabilized through G1 phase in the absence of CDH1. 
 
A Proposed Role For Est1p Degradation 
It is intriguing that each of the stabilized variants of Est1p fails to maintain 
normal length telomeres in an est1Δ background.  However, while I observed rescue of 
telomere length with fusion of the CLB2 D-box sequence for the est1 D-box 2 mutants, 
the half-life of the protein was not decreased, arguing an indirect effect.  I hypothesize 
that this small sequence supports proper protein structure, and thus active Est1p, in a 
manner dependent upon the Arg and Leu residues since mutation to Ala failed to rescue 
telomere length.  Furthermore, overexpression of EST1 for >100 generations did not 
result in a telomere length or cell viability defect.  In fact, the telomeres were elongated 
under these conditions, as has been recently reported [104].  These data suggest there is 
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no detrimental effect from stabilizing Est1p and pose the question: what is the reason for 
Est1p degradation?   
In each cell cycle, only 10% of telomeres are elongated.  Furthermore, telomerase 
preferentially and more substantially extends the shortest telomere ends [130].  This 
elongation coincides with the preferential association of the telomerase complex (Est2p 
and Est1p) with short telomeres in a Tel1p and Xrs2-dependent manner [133,134].  
Additionally, Tel1p does not preferentially associate with the shortest telomeres in the 
absence of Rif2p [133].  Since the number of Est1p molecules is predicted to be <50 
[255] and one critically short telomere is sufficient to cause cellular senescence [258], it 
is logical to target the telomerase complex to the shortest ends.  Perhaps the degradation 
of Est1p is important for resetting the ‘mark’ on the shortest telomeres for elongation.  
For example, the shortest telomeres that are elongated are most likely not going to be the 
shortest in the following cell cycle; therefore, Est1p may be critical for re-establishing the 
association with the appropriate telomere end.  This hypothesis can be tested using the 
STEX assay discussed above.  If degradation of Est1p is critical for re-setting the 
selection of shortest telomeres, overexpression from a high-expression promoter or use of 
a non-degradable allele could alter the pattern of telomere extension and result in hyper-
elongation of telomeres if monitored for multiple cell cycles.  Consistent with this 
hypothesis, telomerase remains tightly associated to its reaction products in vitro [76]; 
however this has not been addressed in vivo due to the technical limitations of 
distinguishing if the same telomerase complex is bound to a particular end following 
elongation.  Therefore, Est1p degradation may be important for removing the telomerase 
complex from the telomere in vivo and/or marking the shortest ends for elongation.  
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The lack of telomere shortening upon EST1 overexpression does not exclude the 
possibility that a pool of Est1p retains regulated degradation in a manner that is important 
for telomere maintenance.  Since Est1p is localized to the nucleus upon overexpression 
([259], Charlene Hawkins, unpublished), regulated degradation could be APC-dependent.  
As hypothesized above, if the reason Est1p is degraded is to re-mark the appropriate 
telomeres for elongation, a subset of molecules may be sufficiently degraded, such as 
those associated with the telomere at the end of S phase.  Unfortunately, a direct test of 
this hypothesis is difficult.   
  
Examining the Usefulness of Standard Techniques 
The standard assays for determining the contribution of the APC to protein 
degradation rely heavily upon protein overexpression.  However, as I have discussed 
above, overexpressed proteins can exhibit degradation patterns that are different than 
endogenously expressed protein.  Overexpressed protein could potentially overwhelm the 
degradation machinery or cause proteolysis through an unnatural pathway.  
Overexpression could also overwhelm necessary pathways for protein modification.  
Monitoring of the half-life by promoter shut-off assay of proteins containing specific 
point mutations is the standard technique for identifying the sequences required for 
protein degradation.  However, it can be difficult to determine if the stabilization 
observed is a direct effect of preventing recognition by the degradation machinery or if it 
results from an indirect effect.  Stabilization of proteins can occur for many reasons, 
including mis-localization and aggregation.  Protein aggregates are generally difficult to 
unfold or degrade and are associated with neurodegenerative diseases such as 
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Alzheimer’s (reviewed in [260,261]).  Monitoring proteins for appropriate localization 
and the absence of aggregated protein by immunofluorescence or through fusion to green 
fluorescent protein (GFP) can begin to address these concerns.  Additionally, since APC 
degron motifs (D-boxes and KEN-boxes) are portable, demonstrating that the wild-type 
sequence identified renders a heterologous protein unstable while a mutated version does 
not, is another established technique that should be utilized to demonstrate that these 
sequences are true degron motifs.   
This type of experiment gets more complicated when examining the effect of 
inhibiting APC activity using ts alleles, such as cdc16-123 or cdc23-1.  To evaluate the 
effect of the APC on endogenously expressed protein, cells must be arrested at the time 
of degradation (G1 phase for instance) and then shifted to the restrictive temperature.  If 
the G1 arrest is not done first, the shift to the restrictive temperature will result in a 
mitotic arrest, where a subset of APC substrates are stable, including Est1p and Clb2p.  
On the other hand, since the APC regulates cyclin degradation, cyclins begin to 
accumulate when the APC is inactivated, resulting in release of the G1 arrest.  To prevent 
this release from G1 phase, overexpression of the CDK inhibitor, SIC1, or deletion of the 
cyclin CLB2 is used [212,216].  Cells can then be held at the restrictive temperature and, 
if the APC contributes to the protein degradation, the protein should accumulate over 
time during the arrest.  However, since mRNA levels of substrates can also be cell-cycle 
regulated, like EST1 and cyclins [101,215,224,262], accumulation may not occur due to 
insufficient translation.  Therefore, the negative result may be uninformative.  
Furthermore, an alpha-factor block and release experiment examining the pattern of 
degradation through the ensuing cell cycle in the presence of an APC ts allele is also not 
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feasible because cells continue to accumulate substrate protein during transit through S 
and G2/M phases, but do not enter a subsequent G1 phase in which degradation could be 
observed [212].  Collectively, I propose that the cell-cycle regulated protein degradation 
field re-evaluate their methodology and begin reporting more results using endogenously 
expressed proteins, when possible.   
  
Summary 
 Yeast telomerase activity is cell cycle regulated in part due to the regulated 
degradation of the Est1 protein subunit during G1 phase.  In this thesis, I have 
demonstrated that the APC regulates the degradation of Est1p during G1 phase in a D-
box dependent manner.  Though in vitro experiments failed to demonstrate a direct-
dependence on the APC, I suggest that the inconsistency with my in vivo work may be 
due to an inactive Est1 protein produced in RRL.  Mutations that result in Est1p 
stabilization shorten telomeres, but overexpression of wild-type EST1 does not.  These 
results suggest that there is no detrimental consequence to overproducing or stabilizing 
Est1p.  Therefore, I suggest that the degradation of Est1p is important for the preferential 
association of telomerase with short telomeres, a function that may be important for 
telomere length regulation but may not be essential for telomere maintenance.  
Understanding the regulation of telomerase complex assembly is essential for complete 
understanding of how telomerase is activated.  
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